-
1
-
-
57349132464
-
Novel naphthalene-N-sulfonyl-D-glutamic acid derivatives as inhibitors of MurD, a key peptidoglycan biosynthesis enzyme
-
Humljan, J.; Kotnik, M.; Contreras-Martel, C; Blanot, D.; Urleb, U.; Dessen, A.a.; S olmajer, T.; Gobec, S. Novel naphthalene-N-sulfonyl-D-glutamic acid derivatives as inhibitors of MurD, a key peptidoglycan biosynthesis enzyme. J. Med. Chem., 2008, 51 (23), 7486-7494.
-
(2008)
J. Med. Chem.
, vol.51
, Issue.23
, pp. 7486-7494
-
-
Humljan, J.1
Kotnik, M.2
Contreras-Martel, C.3
Blanot, D.4
Urleb, U.5
Dessen, A.A.6
Olmajer T, S.7
Gobec, S.8
-
2
-
-
3142617909
-
Sulfonyl-Containing Aldophosphamide Analogues as Novel Anticancer Prodrugs Targeted against Cyclophosphamide-Resistant Tumor Cell Lines
-
Jain, M.; Fan, J.; Baturay, N.Z.; Kwon, C.-H. Sulfonyl-Containing Aldophosphamide Analogues as Novel Anticancer Prodrugs Targeted against Cyclophosphamide-Resistant Tumor Cell Lines. J. Med. Chem., 2004, 47 (15), 3843-3852.
-
(2004)
J. Med. Chem.
, vol.47
, Issue.15
, pp. 3843-3852
-
-
Jain, M.1
Fan, J.2
Baturay, N.Z.3
Kwon, C.-H.4
-
3
-
-
41149177054
-
Inhibition of Carbonic Anhydrases with Glycosyltriazole Benzene Sulfonamides
-
Wilkinson, B.L.; Innocenti, A.; Vullo, D.; Supuran, C.T; Poulsen, S.-A. Inhibition of Carbonic Anhydrases with Glycosyltriazole Benzene Sulfonamides. J. Med. Chem., 2008, 51 (6), 1945-1953.
-
(2008)
J. Med. Chem.
, vol.51
, Issue.6
, pp. 1945-1953
-
-
Wilkinson, B.L.1
Innocenti, A.2
Vullo, D.3
Supuran, C.T.4
Poulsen, S.-A.5
-
4
-
-
79960622162
-
Discovery and Optimization of Sulfonyl Acrylonitriles as Selective, Covalent Inhibitors of Protein Phosphatase Methylesterase-1
-
Bachovchin, D.A.; Zuhl, A.M.; Speers, A.E.; Wolfe, M.R.; Weerapana, E.; Brown, S.J.; Rosen, H.; Cravatt, B.F. Discovery and Optimization of Sulfonyl Acrylonitriles as Selective, Covalent Inhibitors of Protein Phosphatase Methylesterase-1. J. Med. Chem., 2011, 54 (14), 5229-5236.
-
(2011)
J. Med. Chem.
, vol.54
, Issue.14
, pp. 5229-5236
-
-
Bachovchin, D.A.1
Zuhl, A.M.2
Speers, A.E.3
Wolfe, M.R.4
Weerapana, E.5
Brown, S.J.6
Rosen, H.7
Cravatt, B.F.8
-
5
-
-
77949489197
-
Discovering some novel tetrahydroquinoline derivatives bearing the biologically active sulfonamide moiety as a new class of antitumor agents
-
Alqasoumi, S.I.; Al-Taweel, A.M.; Alafeefy, A.M.; Ghorab, MM.; Noaman, E. Discovering some novel tetrahydroquinoline derivatives bearing the biologically active sulfonamide moiety as a new class of antitumor agents. Eur. J. Med. Chem., 2010, 45 (5), 1849-1853.
-
(2010)
Eur. J. Med. Chem.
, vol.45
, Issue.5
, pp. 1849-1853
-
-
Alqasoumi, S.I.1
Al-Taweel, A.M.2
Alafeefy, A.M.3
Ghorab, M.M.4
Noaman, E.5
-
6
-
-
42149114451
-
Diuretics: From Classical Carbonic Anhydrase Inhibitors to Novel Applications of the Sulfonamides
-
Supuran, C.T. Diuretics: From Classical Carbonic Anhydrase Inhibitors to Novel Applications of the Sulfonamides. Curr. Pharm. Des., 2008, 14 (7), 641-648.
-
(2008)
Curr. Pharm. Des.
, vol.14
, Issue.7
, pp. 641-648
-
-
Supuran, C.T.1
-
7
-
-
33747474452
-
Binding of Sulfonyl-Containing Arylalkylamines at Human 5-HT6 Serotonin Receptors
-
Sikazwe, D.; Bondarev, M.L.; Dukat, M.; Rangisetty, J.B.; Roth, B.L.; Glennon, R.A. Binding of Sulfonyl-Containing Arylalkylamines at Human 5-HT6 Serotonin Receptors. J. Med. Chem., 2006, 49 (17), 5217-5225.
-
(2006)
J. Med. Chem.
, vol.49
, Issue.17
, pp. 5217-5225
-
-
Sikazwe, D.1
Bondarev, M.L.2
Dukat, M.3
Rangisetty, J.B.4
Roth, B.L.5
Glennon, R.A.6
-
8
-
-
0038460888
-
Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7)
-
Glennon, R.A. Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7). J. Med. Chem., 2003, 46 (14), 2795-2812.
-
(2003)
J. Med. Chem.
, vol.46
, Issue.14
, pp. 2795-2812
-
-
Glennon, R.A.1
-
9
-
-
64349124929
-
Structure and modeling in the design of ß-and y-secretase inhibitors
-
Holloway, M.K.; Hunt, P.; McGaughey, G.B. Structure and modeling in the design of ß-and y-secretase inhibitors. Drug Dev. Res., 2009, 70 (2), 70-93.
-
(2009)
Drug Dev. Res.
, vol.70
, Issue.2
, pp. 70-93
-
-
Holloway, M.K.1
Hunt, P.2
McGaughey, G.B.3
-
10
-
-
79958067272
-
Identification of Presenilin 1-Selective y-Secretase Inhibitors with Reconstituted y-Secretase Complexes
-
Lee, J.; Song, L.; Terracina, G.; Bara, T.; Josien, H.; Asberom, T.; Sasikumar, T.K.; Burnett, D.A.; Clader, J.; Parker, EM.; Zhang, L. Identification of Presenilin 1-Selective y-Secretase Inhibitors with Reconstituted y-Secretase Complexes. Biochemistry, 2011, 50 (22), 4973-4980.
-
(2011)
Biochemistry
, vol.50
, Issue.22
, pp. 4973-4980
-
-
Lee, J.1
Song, L.2
Terracina, G.3
Bara, T.4
Josien, H.5
Asberom, T.6
Sasikumar, T.K.7
Burnett, D.A.8
Clader, J.9
Parker, E.M.10
Zhang, L.11
-
11
-
-
62249167406
-
Boom in the development of non-peptidic beta-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease
-
Silvestri, R. Boom in the development of non-peptidic beta-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease. Med. Res. Rev., 2009, 29 (2), 295-338.
-
(2009)
Med. Res. Rev.
, vol.29
, Issue.2
, pp. 295-338
-
-
Silvestri, R.1
-
12
-
-
79551705492
-
Development of Proneurogenic, Neuroprotective Small Molecules
-
MacMillan, K.S.; Naidoo, J.; Liang, J.; Melito, L.; Williams, N.S.; Morlock, L.; Huntington, P.J.; Estill, S.J.; Longgood, J.; Becker, G.L.; McKnight, S.L.; Pieper, A.A.; De Brabander, J.K.; Ready, JM. Development of Proneurogenic, Neuroprotective Small Molecules. J. Am. Chem. Soc., 2011, 133 (5), 1428-1437.
-
(2011)
J. Am. Chem. Soc.
, vol.133
, Issue.5
, pp. 1428-1437
-
-
MacMillan, K.S.1
Naidoo, J.2
Liang, J.3
Melito, L.4
Williams, N.S.5
Morlock, L.6
Huntington, P.J.7
Estill, S.J.8
Longgood, J.9
Becker, G.L.10
McKnight, S.L.11
Pieper, A.A.12
De Brabander, J.K.13
Ready, J.M.14
-
13
-
-
61449150645
-
Additivity in the Analysis and Design of HIV Protease Inhibitors
-
Jorissen, R.N.; Reddy, G.S.K.K.; Ali, A.; Altman, M.D.; Chellappan, S.; Anjum, S.G.; Tidor, B.; Schiffer, CA.; Rana, T.M.; Gilson, M.K. Additivity in the Analysis and Design of HIV Protease Inhibitors. J. Med. Chem., 2009, 52 (3), 737-754.
-
(2009)
J. Med. Chem.
, vol.52
, Issue.3
, pp. 737-754
-
-
Jorissen, R.N.1
Reddy, G.S.K.K.2
Ali, A.3
Altman, M.D.4
Chellappan, S.5
Anjum, S.G.6
Tidor, B.7
Schiffer, C.A.8
Rana, T.M.9
Gilson, M.K.10
-
14
-
-
64549155260
-
Indolylarylsulfones Bearing Natural and Unnatural Amino Acids. Discovery of Potent Inhibitors of HIV-1 Non-Nucleoside Wild Type and Resistant Mutant Strains Reverse Transcriptase and Coxsackie B4 Virus
-
Piscitelli, F.; Coluccia, A.; Brancale, A.; La Regina, G.; Sansone, A.; Giordano, C; Balzarini, J.; Maga, G.; Zanoli, S.; Samuele, A.; Cirilli, R.; La Torre, F.; Lavecchia, A.; Novellino, E.; Silvestri, R. Indolylarylsulfones Bearing Natural and Unnatural Amino Acids. Discovery of Potent Inhibitors of HIV-1 Non-Nucleoside Wild Type and Resistant Mutant Strains Reverse Transcriptase and Coxsackie B4 Virus. J. Med. Chem., 2009, 52 (7), 1922-1934.
-
(2009)
J. Med. Chem.
, vol.52
, Issue.7
, pp. 1922-1934
-
-
Piscitelli, F.1
Coluccia, A.2
Brancale, A.3
La Regina, G.4
Sansone, A.5
Giordano, C.6
Balzarini, J.7
Maga, G.8
Zanoli, S.9
Samuele, A.10
Cirilli, R.11
La Torre, F.12
Lavecchia, A.13
Novellino, E.14
Silvestri, R.15
-
15
-
-
0029957413
-
Risk factors for myocardial infarction and death in newly detected NIDDM: The Diabetes Intervention Study, 11-year follow-up
-
Hanefeld, M.; Fischer, S.; Julius, U.; Schulze, J.; Schwanebeck, U.; Schmechel, H.; Ziegelasch, H.J.; Lindner, J. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia, 1996, 39 (12), 1577-1583.
-
(1996)
Diabetologia
, vol.39
, Issue.12
, pp. 1577-1583
-
-
Hanefeld, M.1
Fischer, S.2
Julius, U.3
Schulze, J.4
Schwanebeck, U.5
Schmechel, H.6
Ziegelasch, H.J.7
Lindner, J.8
-
16
-
-
33845468301
-
Alpha-Glucosidase inhibitory activity of the methanolic extract from Tournefortia hartwegiana: An anti hyperglycemic agent
-
Ortiz-Andrade, R.R.; Garcia-Jimenez, S.; Castillo-Espana, P.; Ramirez-Avila, G.; Villalobos-Molina, R.; Estrada-Soto, S. alpha-Glucosidase inhibitory activity of the methanolic extract from Tournefortia hartwegiana: an anti hyperglycemic agent. J. Ethnopharmacol, 2007, 109 (1), 48-53.
-
(2007)
J. Ethnopharmacol
, vol.109
, Issue.1
, pp. 48-53
-
-
Ortiz-Andrade, R.R.1
Garcia-Jimenez, S.2
Castillo-Espana, P.3
Ramirez-Avila, G.4
Villalobos-Molina, R.5
Estrada-Soto, S.6
-
17
-
-
0036297801
-
Glycemic index: Overview of implications in health and disease
-
Jenkins, D.J.A.; Kendall, C.W.C; Augustin, L.S.A.; Franceschi, S.; Hamidi, M.; Marchie, A.; Jenkins, A.L.; Axelsen, M. Glycemic index: Overview of implications in health and disease. Am. J. Clin. Nutr, 2002, 76 (1), 266S-273S.
-
(2002)
Am. J. Clin. Nutr
, vol.76
, Issue.1
-
-
Jenkins, D.J.A.1
Kendall, C.W.C.2
Augustin, L.S.A.3
Franceschi, S.4
Hamidi, M.5
Marchie, A.6
Jenkins, A.L.7
Axelsen, M.8
-
18
-
-
0029050649
-
Inhibition of starch digestion by {alpha}-amylase inhibitor reduces the efficiency of utilization of dietary proteins and lipids and retards the growth of rats
-
Pusztai, A.; Grant, G.; Duguid, T.; Brown, D.S.; Peumans, W.J.; van Damme, E.J.M.; Bardocz, S. Inhibition of starch digestion by {alpha}-amylase inhibitor reduces the efficiency of utilization of dietary proteins and lipids and retards the growth of rats. J. Nutr, 1995, 125 (6), 1554-1562.
-
(1995)
J. Nutr
, vol.125
, Issue.6
, pp. 1554-1562
-
-
Pusztai, A.1
Grant, G.2
Duguid, T.3
Brown, D.S.4
Peumans, W.J.5
Van Damme, E.J.M.6
Bardocz, S.7
-
19
-
-
0037010071
-
Congenital maltase-glucoamylase deficiency associated with lactase and sucrase deficiencies
-
Nichols, B.L.; Avery, S.E.; Karnsakul, W.; Jahoor, F.; Sen, P.; Swallow, DM.; Luginbuehl, U.; Hahn, D.; Sterchi, E.E. Congenital maltase-glucoamylase deficiency associated with lactase and sucrase deficiencies. J. Pediatr. Gastroenterol. Nutr, 2002, 35 (4), 573-579.
-
(2002)
J. Pediatr. Gastroenterol. Nutr
, vol.35
, Issue.4
, pp. 573-579
-
-
Nichols, B.L.1
Avery, S.E.2
Karnsakul, W.3
Jahoor, F.4
Sen, P.5
Swallow, D.M.6
Luginbuehl, U.7
Hahn, D.8
Sterchi, E.E.9
-
20
-
-
60249093549
-
Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes
-
van de Laar, F.A. Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes. Vasc Health Risk Manag, 2008, 4 (6), 1189-1195.
-
(2008)
Vasc Health Risk Manag
, vol.4
, Issue.6
, pp. 1189-1195
-
-
Van De Laar, F.A.1
-
21
-
-
80051783296
-
Cinnamon extract inhibits.alpha.-glucosidase activity and dampens postprandial glucose excursion in diabetic rats
-
doi: 10.1186/1743-7075-1188-1146
-
Shihabudeen H., M.S.; Priscilla D., H.; Thirumurugan, K. Cinnamon extract inhibits.alpha.-glucosidase activity and dampens postprandial glucose excursion in diabetic rats. Nutr. Metab., 2011, 8 (1), doi: 10.1186/1743-7075-1188-1146
-
(2011)
Nutr. Metab.
, vol.8
, Issue.1
-
-
Shihabudeen, H.M.S.1
Priscilla, D.H.2
Thirumurugan, K.3
-
22
-
-
0031722553
-
A potent alpha-glucosidase inhibitor with thiosugar sulfonium sulfate structure, from antidiabetic ayurvedic medicine Salacia reticulata
-
Yoshikawa, M.; Murakami, T.; Yashiro, K.; Matsuda, H. Kotalanol, a potent alpha-glucosidase inhibitor with thiosugar sulfonium sulfate structure, from antidiabetic ayurvedic medicine Salacia reticulata. Chem. Pharm. Bull, 1998, 46 (8), 1339-1340.
-
(1998)
Chem. Pharm. Bull
, vol.46
, Issue.8
, pp. 1339-1340
-
-
Yoshikawa, M.1
Murakami, T.2
Yashiro, K.3
Kotalanol, M.H.4
-
23
-
-
0035821342
-
Glycosidase Inhibition by Cyclic Sulfonium Compounds
-
Yuasa, H.; Takada, J.; Hashimoto, H. Glycosidase Inhibition by Cyclic Sulfonium Compounds. Bioorg. Med. Chem. Lett, 2001, 11 (9), 1137-1139.
-
(2001)
Bioorg. Med. Chem. Lett
, vol.11
, Issue.9
, pp. 1137-1139
-
-
Yuasa, H.1
Takada, J.2
Hashimoto, H.3
-
24
-
-
34247333428
-
Biological evaluation of de-O-sulfonated analogs of salacinol, the role of sulfate anion in the side chain on the a-glucosidase inhibitory activity
-
Tanabe, G.; Yoshikai, K.; Hatanaka, T.; Yamamoto, M.; Shao, Y; Minematsu, T.; Muraoka, O.; Wang, T.; Matsuda, H.; Yoshikawa, M. Biological evaluation of de-O-sulfonated analogs of salacinol, the role of sulfate anion in the side chain on the a-glucosidase inhibitory activity. Bioorg. Med. Chem., 2007, 15 (11), 3926-3937.
-
(2007)
Bioorg. Med. Chem.
, vol.15
, Issue.11
, pp. 3926-3937
-
-
Tanabe, G.1
Yoshikai, K.2
Hatanaka, T.3
Yamamoto, M.4
Shao, Y.5
Minematsu, T.6
Muraoka, O.7
Wang, T.8
Matsuda, H.9
Yoshikawa, M.10
-
25
-
-
27644560989
-
Sulfonamide chalcone as a new class of a-glucosidase inhibitors
-
Seo, W.D.; Kim, J.H.; Kang, J.E.; Ryu, H.W.; Curtis-Long, M.J.; Lee, H.S.; Yang, M.S.; Park, K.H. Sulfonamide chalcone as a new class of a-glucosidase inhibitors. Bioorg. Med. Chem. Lett, 2005, 15 (24), 5514-5516.
-
(2005)
Bioorg. Med. Chem. Lett
, vol.15
, Issue.24
, pp. 5514-5516
-
-
Seo, W.D.1
Kim, J.H.2
Kang, J.E.3
Ryu, H.W.4
Curtis-Long, M.J.5
Lee, H.S.6
Yang, M.S.7
Park, K.H.8
-
26
-
-
75849129602
-
Synthesis and evaluation of the [alpha]-glucosidase inhibitory activity of 3-[4-(phenylsulfonamido)benzoyl]-2H-1-benzopyran-2-one derivatives
-
Wang, S.; Yan, J.; Wang, X.; Yang, Z.; Lin, F.; Zhang, T. Synthesis and evaluation of the [alpha]-glucosidase inhibitory activity of 3-[4-(phenylsulfonamido)benzoyl]-2H-1-benzopyran-2-one derivatives. Eur. J. Med. Chem., 2010, 45 (3), 1250-1255.
-
(2010)
Eur. J. Med. Chem.
, vol.45
, Issue.3
, pp. 1250-1255
-
-
Wang, S.1
Yan, J.2
Wang, X.3
Yang, Z.4
Lin, F.5
Zhang, T.6
-
27
-
-
64249101080
-
Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates
-
Luiken, J.J.F.P; Niessen, H.E.C.; Coort, S.L.M.; Hoebers, N; Coumans, W.A.; Schwenk, R.W.; Bonen, A.; Glatz, J.F.C. Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates. Biochem. J., 2009, 419 (2), 447-455.
-
(2009)
Biochem. J.
, vol.419
, Issue.2
, pp. 447-455
-
-
Luiken, J.J.F.P.1
Niessen, H.E.C.2
Coort, S.L.M.3
Hoebers, N.4
Coumans, W.A.5
Schwenk, R.W.6
Bonen, A.7
Glatz, J.F.C.8
-
28
-
-
0018864840
-
Regulation of hepatic fatty acid oxidation and ketone body production
-
McGarry, J.D.; Foster, D.W. Regulation of hepatic fatty acid oxidation and ketone body production. Annu. Rev. Biochem., 1980, 49, 395-420.
-
(1980)
Annu. Rev. Biochem.
, vol.49
, pp. 395-420
-
-
McGarry, J.D.1
Foster, D.W.2
-
29
-
-
0024503204
-
Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase
-
McGarry, J.D.; Woeltje, K.F.; Kuwajima, M.; Foster, D.W. Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase. Diabetes Metab. Rev, 1989, 5 (3), 271-284.
-
(1989)
Diabetes Metab. Rev
, vol.5
, Issue.3
, pp. 271-284
-
-
McGarry, J.D.1
Woeltje, K.F.2
Kuwajima, M.3
Foster, D.W.4
-
30
-
-
0021024932
-
Carnitine-metabolism and functions
-
Bremer, J. Carnitine-metabolism and functions. Physiol. Rev, 1983, 63 (4), 1420-1480.
-
(1983)
Physiol. Rev
, vol.63
, Issue.4
, pp. 1420-1480
-
-
Bremer, J.1
-
31
-
-
0031043030
-
The mitochondrial carnitine palmitoyltransferase system. from concept to molecular analysis
-
McGarry, J.D.; Brown, N.F. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur. J. Biochem., 1997, 244 (1), 1-14.
-
(1997)
Eur. J. Biochem.
, vol.244
, Issue.1
, pp. 1-14
-
-
McGarry, J.D.1
Brown, N.F.2
-
32
-
-
0028091713
-
Use of a selective inhibitor of liver carnitine palmitoyltransferase i (CPT I) allows quantification of its contribution to total CPT i activity in rat heart. Evidence that the dominant cardiac CPT i isoform is identical to the skeletal muscle enzyme
-
Weis, B.C.; Cowan, A.T.; Brown, N; Foster, D.W.; McGarry, J.D. Use of a selective inhibitor of liver carnitine palmitoyltransferase I (CPT I) allows quantification of its contribution to total CPT I activity in rat heart. Evidence that the dominant cardiac CPT I isoform is identical to the skeletal muscle enzyme. J. Biol. Chem., 1994, 269 (42), 26443-26448.
-
(1994)
J. Biol. Chem.
, vol.269
, Issue.42
, pp. 26443-26448
-
-
Weis, B.C.1
Cowan, A.T.2
Brown, N.3
Foster, D.W.4
McGarry, J.D.5
-
33
-
-
0031771423
-
Synthesis of 2-[6-(2, 4-Dinitrophenoxy)hexyl]oxiranecarboxylic acid: A selective carnitine palmitoyltransferase-1 inhibitor
-
Hutchison, T.L.; Brouillette, W.J. Synthesis of 2-[6-(2, 4-Dinitrophenoxy)hexyl]oxiranecarboxylic acid: A selective carnitine palmitoyltransferase-1 inhibitor. Bioorg. Med. Chem., 1998, 6 (11), 2133-2138.
-
(1998)
Bioorg. Med. Chem.
, vol.6
, Issue.11
, pp. 2133-2138
-
-
Hutchison, T.L.1
Brouillette, W.J.2
-
34
-
-
0037448389
-
Discovery of a Long-Chain Carbamoyl Amino carnitine Derivative, a Reversible Carnitine Palmitoyltransferase Inhibitor with Antiketotic and Antidiabetic Activity
-
Giannessi, F.; Pessotto, P.; Tassoni, E.; Chiodi, P.; Conti, R.; De Angelis, F.; DellUomo, N; Catini, R.; Deias, R.; Tinti, M.O.; Carminati, P.; Arduini, A. Discovery of a Long-Chain Carbamoyl Amino carnitine Derivative, a Reversible Carnitine Palmitoyltransferase Inhibitor with Antiketotic and Antidiabetic Activity. J. Med. Chem., 2003, 46 (2), 303-309.
-
(2003)
J. Med. Chem.
, vol.46
, Issue.2
, pp. 303-309
-
-
Giannessi, F.1
Pessotto, P.2
Tassoni, E.3
Chiodi, P.4
Conti, R.5
De Angelis, F.6
Delluomo, N.7
Catini, R.8
Deias, R.9
Tinti, M.O.10
Carminati, P.11
Arduini, A.12
-
35
-
-
0035913058
-
Reversible Carnitine Palmitoyltransferase Inhibitors with Broad Chemical Diversity as Potential Antidiabetic Agents
-
Giannessi, F.; Chiodi, P.; Marzi, M.; Minetti, P.; Pessotto, P.; De Angelis, F.; Tassoni, E.; Conti, R.; Giorgi, F.; Mabilia, M.; Dell'Uomo, N.; Muck, S.; Tinti, M.O.; Carminati, P.; Arduini, A. Reversible Carnitine Palmitoyltransferase Inhibitors with Broad Chemical Diversity as Potential Antidiabetic Agents. J. Med. Chem., 2001, 44 (15), 2383-2386.
-
(2001)
J. Med. Chem.
, vol.44
, Issue.15
, pp. 2383-2386
-
-
Giannessi, F.1
Chiodi, P.2
Marzi, M.3
Minetti, P.4
Pessotto, P.5
De Angelis, F.6
Tassoni, E.7
Conti, R.8
Giorgi, F.9
Mabilia, M.10
Dell'Uomo, N.11
Muck, S.12
Tinti, M.O.13
Carminati, P.14
Arduini, A.15
-
36
-
-
0029131453
-
Antidiabetic agents: A new class of reversible carnitine palmitoyltransferase i inhibitors
-
Anderson, R.C.; Balestra, M.; Bell, P.A.; Deems, R.O.; Fillers, W.S.; Foley, J.E.; Fraser, J.D.; Mann, W.R.; Rudin, M.; Villhauer, E.B. Antidiabetic agents: a new class of reversible carnitine palmitoyltransferase I inhibitors. J. Med. Chem., 1995, 38 (18), 3448-3450.
-
(1995)
J. Med. Chem.
, vol.38
, Issue.18
, pp. 3448-3450
-
-
Anderson, R.C.1
Balestra, M.2
Bell, P.A.3
Deems, R.O.4
Fillers, W.S.5
Foley, J.E.6
Fraser, J.D.7
Mann, W.R.8
Rudin, M.9
Villhauer, E.B.10
-
37
-
-
0026590484
-
Pathogenesis of NIDDM: A balanced overview
-
DeFronzo, R.A.; Bonadonna, R.C.; Ferranini, E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care, 1992, 15 (3), 318-368.
-
(1992)
Diabetes Care
, vol.15
, Issue.3
, pp. 318-368
-
-
Defronzo, R.A.1
Bonadonna, R.C.2
Ferranini, E.3
-
38
-
-
0023189066
-
Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin- dependent diabetic individuals
-
Golay, A.; Swislocki, A.L.M.; Chen, Y.D.; Reaven, G.M. Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals. Metabolism., 1987, 36 (7), 692-696.
-
(1987)
Metabolism.
, vol.36
, Issue.7
, pp. 692-696
-
-
Golay, A.1
Swislocki, A.L.M.2
Chen, Y.D.3
Reaven, G.M.4
-
39
-
-
0026721574
-
Rationale and Application of Fatty Acid Oxidation Inhibitors in Treatment of Diabetes Mellitus
-
Foley, J.E. Rationale and Application of Fatty Acid Oxidation Inhibitors in Treatment of Diabetes Mellitus. Diabetes Care, 1992, 15 (6), 773-784.
-
(1992)
Diabetes Care
, vol.15
, Issue.6
, pp. 773-784
-
-
Foley, J.E.1
-
40
-
-
0031936058
-
Carnitine Palmitoyltransferase: A Viable Target for the Treatment of NIDDM?
-
Anderson, R. Carnitine Palmitoyltransferase: A Viable Target for the Treatment of NIDDM? Curr. Pharm. Des., 1998, 4 (1), 1-16.
-
(1998)
Curr. Pharm. Des.
, vol.4
, Issue.1
, pp. 1-16
-
-
Anderson, R.1
-
41
-
-
0036092239
-
Banting lecture 2001: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes
-
McGarry, J.D. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diatetes, 2002, 51 (1), 7-18.
-
(2002)
Diatetes
, vol.51
, Issue.1
, pp. 7-18
-
-
McGarry, J.D.1
-
42
-
-
0029862741
-
Expression of a cDNA isolated from rat brown adipose tissue and heart identifies the product as the muscle isoform of carnitine palmitoyltransferase i (M-CPT I) M-CPT i is the predominant CPT i isoform expressed in both white (epididymal) and brown adipocytes
-
Esser, V.; Brown, N.; Cowan, A.T.; Foster, D.W.; McGarry, J.D. Expression of a cDNA isolated from rat brown adipose tissue and heart identifies the product as the muscle isoform of carnitine palmitoyltransferase I (M-CPT I). M-CPT I is the predominant CPT I isoform expressed in both white (epididymal) and brown adipocytes. J. Biol. Chem., 1996, 271 (12), 6972-6977.
-
(1996)
J. Biol. Chem.
, vol.271
, Issue.12
, pp. 6972-6977
-
-
Esser, V.1
Brown, N.2
Cowan, A.T.3
Foster, D.W.4
McGarry, J.D.5
-
43
-
-
0024401731
-
Chronic inhibition of fatty acid oxidation: New model of diastolic dysfunction
-
Bressler, R.; Gay, R.; Copeland, J.G.; Bahl, J.J.; Bedotto, J.; Goldman, S. Chronic inhibition of fatty acid oxidation: New model of diastolic dysfunction. Life Sci., 1989, 44 (25), 1897-1906.
-
(1989)
Life Sci.
, vol.44
, Issue.25
, pp. 1897-1906
-
-
Bressler, R.1
Gay, R.2
Copeland, J.G.3
Bahl, J.J.4
Bedotto, J.5
Goldman, S.6
-
44
-
-
84863737395
-
-
US20060276494
-
Bleicher, K.; Ceccarelli, S.M.; Chomienne, O.; Mattei, P.; Schulz-Gasch, T.; Stahl, C.M. Preparation of N-phenylsulfonamides as liver carnitine palmitoyl transferase 1 (L-CPT1) inhibitors for the treatment of hyperglycemia and glucose tolerance disorders. US20060276494, 2006.
-
(2006)
Preparation of N-phenylsulfonamides As Liver Carnitine Palmitoyl Transferase 1 (L-CPT1) Inhibitors for the Treatment of Hyperglycemia and Glucose Tolerance Disorders
-
-
Bleicher, K.1
Ceccarelli, S.M.2
Chomienne, O.3
Mattei, P.4
Schulz-Gasch, T.5
Stahl, C.M.6
-
45
-
-
84863761918
-
-
US20070060567
-
Ackermann, J.; Bleicher, K.; Ceccarelli Grenz, S.M.; Chomienne, O.; Mattei, P.; Schulz-Gasch, T. Preparation of N-(benzenesulfonyl)-2, 3-dihydro-1H-indole-6-carboxamide derivatives as inhibitors of liver carnitine-dependent palmitoyltransferase 1 (L-CPT1). US20070060567, 2007.
-
(2007)
Preparation of N-(benzenesulfonyl)-2, 3-dihydro-1H-indole-6-carboxamide Derivatives As Inhibitors of Liver Carnitine-dependent Palmitoyltransferase 1 (L-CPT1)
-
-
Ackermann, J.1
Bleicher, K.2
Ceccarelli Grenz, S.M.3
Chomienne, O.4
Mattei, P.5
Schulz-Gasch, T.6
-
46
-
-
84863732567
-
-
WO2007093507
-
Ackermann, J.; Bleicher, K.; Ceccarelli, S.M.; Chomienne, O.; Mattei, P.; Obst Sander, U. Preparation of phenylsulfonyl heterocycles as liver carnitine palmitoyl transferase 1 (L-CPT1) inhibitors. WO2007093507, 2007.
-
(2007)
Preparation of Phenylsulfonyl Heterocycles As Liver Carnitine Palmitoyl Transferase 1 (L-CPT1) Inhibitors
-
-
Ackermann, J.1
Bleicher, K.2
Ceccarelli, S.M.3
Chomienne, O.4
Mattei, P.5
Obst Sander, U.6
-
48
-
-
0030067124
-
Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm
-
Matschinsky, F.M. Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes, 1996, 45 (2), 223-241.
-
(1996)
Diabetes
, vol.45
, Issue.2
, pp. 223-241
-
-
Matschinsky, F.M.1
-
49
-
-
0031892853
-
Pancreatic beta-cell glucokinase: Closing the gap between theoretical concepts and experimental realities
-
Matschinsky, F.M.; Glaser, B.; Magnuson, M.A. Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities. Diabetes, 1998, 47 (3), 307-315.
-
(1998)
Diabetes
, vol.47
, Issue.3
, pp. 307-315
-
-
Matschinsky, F.M.1
Glaser, B.2
Magnuson, M.A.3
-
50
-
-
1542791635
-
Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase
-
Kamata, K.; Mitsuya, M.; Nishimura, T.; Eiki, J.I.; Nagata, Y. Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase. Structure, 2004, 12 (3), 429-438.
-
(2004)
Structure
, vol.12
, Issue.3
, pp. 429-438
-
-
Kamata, K.1
Mitsuya, M.2
Nishimura, T.3
Eiki, J.I.4
Nagata, Y.5
-
51
-
-
33745043238
-
Small Molecule Glucokinase Activators as Glucose Lowering Agents: A New Paradigm for Diabetes Therapy
-
Guertin, K.R.; Grimsby, J. Small Molecule Glucokinase Activators as Glucose Lowering Agents: A New Paradigm for Diabetes Therapy. Curr. Med. Chem., 2006, 13 (15), 1839-1843.
-
(2006)
Curr. Med. Chem.
, vol.13
, Issue.15
, pp. 1839-1843
-
-
Guertin, K.R.1
Grimsby, J.2
-
52
-
-
39049086785
-
Glucokinase activators in diabetes management
-
Coghlan, M.; Leighton, B. Glucokinase activators in diabetes management. Exp. Opin. Invest. Drugs, 2008, 17 (2), 145-167.
-
(2008)
Exp. Opin. Invest. Drugs
, vol.17
, Issue.2
, pp. 145-167
-
-
Coghlan, M.1
Leighton, B.2
-
53
-
-
48049120189
-
Glucokinase activators as new type 2 diabetes therapeutic agents
-
Sarabu, R.; Berthel, S.J.; Kester, R.F.; Tilley, J.W. Glucokinase activators as new type 2 diabetes therapeutic agents. Exp. Opin. Ther. Patents, 2008, 18 (7), 759-768.
-
(2008)
Exp. Opin. Ther. Patents
, vol.18
, Issue.7
, pp. 759-768
-
-
Sarabu, R.1
Berthel, S.J.2
Kester, R.F.3
Tilley, J.W.4
-
54
-
-
23844550012
-
A novel glucokinase activator modulates pancreatic islet and hepatocyte function
-
Efanov, A.M.; Barrett, D.G.; Brenner, B.M.; Briggs, S.L.; Delaunois, A.; Durbin, J.D.; Giese, U.; Guo, H.; Radloff, M.; Sanz, G.G.; Sewing, S.; Wang, Y.; Weichert, A.; Zaliani, A.; Gromada, J. A novel glucokinase activator modulates pancreatic islet and hepatocyte function. Endocrinology, 2005, 136 (9), 2696-2701.
-
(2005)
Endocrinology
, vol.136
, Issue.9
, pp. 2696-2701
-
-
Efanov, A.M.1
Barrett, D.G.2
Brenner, B.M.3
Briggs, S.L.4
Delaunois, A.5
Durbin, J.D.6
Giese, U.7
Guo, H.8
Radloff, M.9
Sanz, G.G.10
Sewing, S.11
Wang, Y.12
Weichert, A.13
Zaliani, A.14
Gromada, J.15
-
55
-
-
47749124955
-
SAR, pharmacokinetics, safety, and efficacy of glucokinase activating 2-(4-sulfonylphenyl)-N-thiazol-2-ylacetamides: Discovery of PSN-GK1
-
Bertram, L.S.; Black, D.; Briner, P.H.; Chatfield, R.; Cooke, A.; Fyfe, M.C.T.; Murray, P.J.; Naud, F.; Nawano, M.; Procter, M.J.; Rakipovski, G.; Rasamison, C.M.; Reynet, C.; Schofield, K.L.; Shah, V.K.; Spindler, F.; Taylor, A.; Turton, R.; Williams, G.M.; Wong-Kai-In, P.; Yasuda, K. SAR, pharmacokinetics, safety, and efficacy of glucokinase activating 2-(4-sulfonylphenyl)-N-thiazol-2-ylacetamides: discovery of PSN-GK1. J. Med. Chem., 2008, 51 (14), 4340-4345.
-
(2008)
J. Med. Chem.
, vol.51
, Issue.14
, pp. 4340-4345
-
-
Bertram, L.S.1
Black, D.2
Briner, P.H.3
Chatfield, R.4
Cooke, A.5
Fyfe, M.C.T.6
Murray, P.J.7
Naud, F.8
Nawano, M.9
Procter, M.J.10
Rakipovski, G.11
Rasamison, C.M.12
Reynet, C.13
Schofield, K.L.14
Shah, V.K.15
Spindler, F.16
Taylor, A.17
Turton, R.18
Williams, G.M.19
Wong-Kai-In, P.20
Yasuda, K.21
more..
-
56
-
-
0037624071
-
Allosteric activators of glucokinase: Potential role in diabetes therapy
-
Grimsby, J.; Sarabu, R.; Corbett, W.L.; Haynes, N.E.; Bizzarro, F.T.; Coffey, J.W.; Guertin, K.R.; Hilliard, D.W.; Kester, R.F.; Mahaney, P.E.; Marcus, L.; Qi, L.D.; Spence, C.L.; Tengi, J.; Magnuson, M.A.; Chu, C.A.; Dvorozniak, M.T.; Matschinsky, F.M.; Grippo, J.F. Allosteric activators of glucokinase: potential role in diabetes therapy. Science, 2003, 301 (5631), 370-373.
-
(2003)
Science
, vol.301
, Issue.5631
, pp. 370-373
-
-
Grimsby, J.1
Sarabu, R.2
Corbett, W.L.3
Haynes, N.E.4
Bizzarro, F.T.5
Coffey, J.W.6
Guertin, K.R.7
Hilliard, D.W.8
Kester, R.F.9
Mahaney, P.E.10
Marcus, L.11
Qi, L.D.12
Spence, C.L.13
Tengi, J.14
Magnuson, M.A.15
Chu, C.A.16
Dvorozniak, M.T.17
Matschinsky, F.M.18
Grippo, J.F.19
-
57
-
-
34247862169
-
Glucokinase activator PSNGK1 displays enhanced antihyperglycemic and insulinotropic actions
-
Fyfe, M.C.T.; White, J.; Taylor, A.; Chatfield, R.; Wargent, E.; Printz, R.L.; Sulpice, T.; McCormack, J.G.; Procter, M.J.; Reynet, C.; Widdowson, P.S.; Wong-kai-in, P. Glucokinase activator PSNGK1 displays enhanced antihyperglycemic and insulinotropic actions. Diabetologia, 2007, 50 (6), 1277-1287.
-
(2007)
Diabetologia
, vol.50
, Issue.6
, pp. 1277-1287
-
-
Fyfe, M.C.T.1
White, J.2
Taylor, A.3
Chatfield, R.4
Wargent, E.5
Printz, R.L.6
Sulpice, T.7
McCormack, J.G.8
Procter, M.J.9
Reynet, C.10
Widdowson, P.S.11
Wong-Kai-In, P.12
-
58
-
-
77953131053
-
Design synthesis, and pharmacological evaluation of N-(4-mono and 4, 5-disubstituted thiazol-2-yl)-2-aryl-3-(tetrahydro-2H-pyran-4-yl)propanamides as glucokinase activators
-
Li, F.; Zhu, Q.; Zhang, Y.; Feng, Y.; Leng, Y.; Zhang, A. Design, synthesis, and pharmacological evaluation of N-(4-mono and 4, 5-disubstituted thiazol-2-yl)-2-aryl-3-(tetrahydro-2H-pyran-4-yl)propanamides as glucokinase activators. Bioorg. Med. Chem., 2010, 18 (11), 3875-3884.
-
(2010)
Bioorg. Med. Chem.
, vol.18
, Issue.11
, pp. 3875-3884
-
-
Li, F.1
Zhu, Q.2
Zhang, Y.3
Feng, Y.4
Leng, Y.5
Zhang, A.6
-
59
-
-
70349641037
-
Investigation of Functionally Liver Selective Glucokinase Activators for the Treatment of Type 2 Diabetes
-
Bebernitz, G.R.; Beaulieu, V.; Dale, B.A.; Deacon, R.; Duttaroy, A.; Gao, J.; Grondine, M.S.; Gupta, R.C.; Kakmak, M.; Kavana, M.; Kirman, L.C.; Liang, J.; Maniara, W.M.; Munshi, S.; Nadkarni, S.S.; Schuster, H.F.; Stams, T.; St. Denny, I.; Taslimi, P.M.; Vash, B.; Caplan, S.L. Investigation of Functionally Liver Selective Glucokinase Activators for the Treatment of Type 2 Diabetes. J. Med. Chem., 2009, 52 (19), 6142-6152.
-
(2009)
J. Med. Chem.
, vol.52
, Issue.19
, pp. 6142-6152
-
-
Bebernitz, G.R.1
Beaulieu, V.2
Dale, B.A.3
Deacon, R.4
Duttaroy, A.5
Gao, J.6
Grondine, M.S.7
Gupta, R.C.8
Kakmak, M.9
Kavana, M.10
Kirman, L.C.11
Liang, J.12
Maniara, W.M.13
Munshi, S.14
Nadkarni, S.S.15
Schuster, H.F.16
Stams, T.17
St. Denny, I.18
Taslimi, P.M.19
Vash, B.20
Caplan, S.L.21
more..
-
60
-
-
84863767152
-
-
WO2004050645
-
Weichert, A.G.; Barrett, D.G.; Heuser, S.; Riedl, R.; Tebbe, M.J.; Zaliani, A. Substituted (Thiazol-2-yl)-Amide or Sulfonamide as Glycokinase Activators Useful in The Treatment Of Type 2 Diabetes. WO2004050645, 2004.
-
(2004)
Substituted (Thiazol-2-yl)-Amide or Sulfonamide As Glycokinase Activators Useful in the Treatment of Type 2 Diabetes
-
-
Weichert, A.G.1
Barrett, D.G.2
Heuser, S.3
Riedl, R.4
Tebbe, M.J.5
Zaliani, A.6
-
61
-
-
84863762048
-
-
WO2004063194
-
Weichert, A.G.; Barrett, D.G.; Heuser, S.; Riedl, R.; Tebbe, M.J.; Zaliani, A. Heteroaryl Compounds. WO2004063194, 2004.
-
(2004)
Heteroaryl Compounds
-
-
Weichert, A.G.1
Barrett, D.G.2
Heuser, S.3
Riedl, R.4
Tebbe, M.J.5
Zaliani, A.6
-
62
-
-
13944280917
-
Glucokinase-activating ureas
-
Castelhano, A.L.; Dong, H.; Fyfe, M.C.T.; Gardner, L.S.; Kamikozawa, Y.; Kurabayashi, S.; Nawano, M.; Ohashi, R.; Procter, M.J.; Qiu, L.; Rasamison, C.M.; Schofield, K.L.; Shah, V.K.; Ueta, K.; Williams, G.M.; Witter, D.; Yasuda, K. Glucokinase-activating ureas. Bioorg. Med. Chem. Lett., 2005, 15 (5), 1501-1504.
-
(2005)
Bioorg. Med. Chem. Lett.
, vol.15
, Issue.5
, pp. 1501-1504
-
-
Castelhano, A.L.1
Dong, H.2
Fyfe, M.C.T.3
Gardner, L.S.4
Kamikozawa, Y.5
Kurabayashi, S.6
Nawano, M.7
Ohashi, R.8
Procter, M.J.9
Qiu, L.10
Rasamison, C.M.11
Schofield, K.L.12
Shah, V.K.13
Ueta, K.14
Williams, G.M.15
Witter, D.16
Yasuda, K.17
-
63
-
-
77957566729
-
2, 3-Disubstituted acrylamides as potent glucokinase activators
-
Sidduri, A.; Grimsby, J.S.; Corbett, W.L.; Sarabu, R.; Grippo, J.F.; Lou, J.; Kester, R.F.; Dvorozniak, M.; Marcus, L.; Spence, C.; Racha, J.K.; Moore, D.J. 2, 3-Disubstituted acrylamides as potent glucokinase activators. Bioorg. Med. Chem. Lett., 2010, 20 (19), 5673-5676.
-
(2010)
Bioorg. Med. Chem. Lett.
, vol.20
, Issue.19
, pp. 5673-5676
-
-
Sidduri, A.1
Grimsby, J.S.2
Corbett, W.L.3
Sarabu, R.4
Grippo, J.F.5
Lou, J.6
Kester, R.F.7
Dvorozniak, M.8
Marcus, L.9
Spence, C.10
Racha, J.K.11
Moore, D.J.12
-
64
-
-
62949154988
-
Discovery of potent and orally active 3-alkoxy-5-phenoxy-N-thiazolyl benzamides as novel allosteric glucokinase activators
-
Iino, T.; Tsukahara, D.; Kamata, K.; Sasaki, K.; Ohyama, S.; Hosaka, H.; Hasegawa, T.; Chiba, M.; Nagata, Y.; Eiki, J.-i.; Nishimura, T. Discovery of potent and orally active 3-alkoxy-5-phenoxy-N-thiazolyl benzamides as novel allosteric glucokinase activators. Bioorg. Med. Chem., 2009, 17 (7), 2733-2743.
-
(2009)
Bioorg. Med. Chem.
, vol.17
, Issue.7
, pp. 2733-2743
-
-
Iino, T.1
Tsukahara, D.2
Kamata, K.3
Sasaki, K.4
Ohyama, S.5
Hosaka, H.6
Hasegawa, T.7
Chiba, M.8
Nagata, Y.9
Eiki, J.-I.10
Nishimura, T.11
-
65
-
-
65549120038
-
Structure-activity relationships of 3, 5-disubstituted benzamides as glucokinase activators with potent in vivo efficacy
-
Iino, T.; Hashimoto, N.; Sasaki, K.; Ohyama, S.; Yoshimoto, R.; Hosaka, H.; Hasegawa, T.; Chiba, M.; Nagata, Y.; Eiki, J.-i.; Nishimura, T. Structure-activity relationships of 3, 5-disubstituted benzamides as glucokinase activators with potent in vivo efficacy. Bioorg. Med. Chem., 2009, 17 (11), 3800-3809.
-
(2009)
Bioorg. Med. Chem.
, vol.17
, Issue.11
, pp. 3800-3809
-
-
Iino, T.1
Hashimoto, N.2
Sasaki, K.3
Ohyama, S.4
Yoshimoto, R.5
Hosaka, H.6
Hasegawa, T.7
Chiba, M.8
Nagata, Y.9
Eiki, J.-I.10
Nishimura, T.11
-
66
-
-
67649934727
-
Discovery of novel 2-(pyridine-2-yl)-1H-benzimidazole derivatives as potent glucokinase activators
-
Ishikawa, M.; Nonoshita, K.; Ogino, Y.; Nagae, Y.; Tsukahara, D.; Hosaka, H.; Maruki, H.; Ohyama, S.; Yoshimoto, R.; Sasaki, K.; Nagata, Y.; Eiki, J.i.; Nishimura, T. Discovery of novel 2-(pyridine-2-yl)-1H-benzimidazole derivatives as potent glucokinase activators. Bioorg. Med. Chem. Lett., 2009, 19 (15), 4450-4454.
-
(2009)
Bioorg. Med. Chem. Lett.
, vol.19
, Issue.15
, pp. 4450-4454
-
-
Ishikawa, M.1
Nonoshita, K.2
Ogino, Y.3
Nagae, Y.4
Tsukahara, D.5
Hosaka, H.6
Maruki, H.7
Ohyama, S.8
Yoshimoto, R.9
Sasaki, K.10
Nagata, Y.11
Eiki, J.I.12
Nishimura, T.13
-
67
-
-
69949164182
-
The design and optimization of a series of 2-(pyridin-2-yl)-1H- benzimidazole compounds as allosteric glucokinase activators
-
Takahashi, K.; Hashimoto, N.; Nakama, C.; Kamata, K.; Sasaki, K.; Yoshimoto, R.; Ohyama, S.; Hosaka, H.; Maruki, H.; Nagata, Y.; Eiki, J.-i.; Nishimura, T. The design and optimization of a series of 2-(pyridin-2-yl)-1H- benzimidazole compounds as allosteric glucokinase activators. Bioorg. Med. Chem., 2009, 17 (19), 7042-7051.
-
(2009)
Bioorg. Med. Chem.
, vol.17
, Issue.19
, pp. 7042-7051
-
-
Takahashi, K.1
Hashimoto, N.2
Nakama, C.3
Kamata, K.4
Sasaki, K.5
Yoshimoto, R.6
Ohyama, S.7
Hosaka, H.8
Maruki, H.9
Nagata, Y.10
Eiki, J.-I.11
Nishimura, T.12
-
68
-
-
69949100799
-
Discovery and structure-activity relationships of a novel class of quinazoline glucokinase activators
-
Iino, T.; Sasaki, Y.; Bamba, M.; Mitsuya, M.; Ohno, A.; Kamata, K.; Hosaka, H.; Maruki, H.; Futamura, M.; Yoshimoto, R.; Ohyama, S.; Sasaki, K.; Chiba, M.; Ohtake, N.; Nagata, Y.; Eiki, J.-i.; Nishimura, T. Discovery and structure-activity relationships of a novel class of quinazoline glucokinase activators. Bioorg. Med. Chem. Lett., 2009, 19 (19), 5531-5538.
-
(2009)
Bioorg. Med. Chem. Lett.
, vol.19
, Issue.19
, pp. 5531-5538
-
-
Iino, T.1
Sasaki, Y.2
Bamba, M.3
Mitsuya, M.4
Ohno, A.5
Kamata, K.6
Hosaka, H.7
Maruki, H.8
Futamura, M.9
Yoshimoto, R.10
Ohyama, S.11
Sasaki, K.12
Chiba, M.13
Ohtake, N.14
Nagata, Y.15
Eiki, J.-I.16
Nishimura, T.17
-
69
-
-
0033540056
-
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
-
Kojima, M.; Hosoda, H.; Date, Y.; Nakazato, M.; Matsuo, H.; Kangawa, K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 1999, 402 (6762), 656-660.
-
(1999)
Nature
, vol.402
, Issue.6762
, pp. 656-660
-
-
Kojima, M.1
Hosoda, H.2
Date, Y.3
Nakazato, M.4
Matsuo, H.5
Kangawa, K.6
-
70
-
-
0034687376
-
Ghrelin induces adiposity in rodents
-
Tschop, M.; Smiley, D.L.; Heiman, M.L. Ghrelin induces adiposity in rodents. Nature, 2000, 407 (6806), 908-913.
-
(2000)
Nature
, vol.407
, Issue.6806
, pp. 908-913
-
-
Tschop, M.1
Smiley, D.L.2
Heiman, M.L.3
-
71
-
-
0035843183
-
A role for ghrelin in the central regulation of feeding
-
Nakazato, M.; Murakami, N.; Date, Y.; Kojima, M.; Matsuo, H.; Kangawa, K.; Matsukura, S. A role for ghrelin in the central regulation of feeding. Nature, 2001, 409 (6817), 194-198.
-
(2001)
Nature
, vol.409
, Issue.6817
, pp. 194-198
-
-
Nakazato, M.1
Murakami, N.2
Date, Y.3
Kojima, M.4
Matsuo, H.5
Kangawa, K.6
Matsukura, S.7
-
72
-
-
0034035943
-
Type 2 diabetes among North American children and adolescents: An epidemiological review and a public health perspective
-
Fagot-Campagna, A.; Pettitt, D.J.; Engelgau, M.M.; Burrows, N.R.; Geiss, L.S.; Baldez, R.; Beckles, G.I.; Saaddine, J.; Gregg, E.W.; Williamson, D.F.; Narayan, K.M.V. Type 2 diabetes among North American children and adolescents: an epidemiological review and a public health perspective. J. Pediatr., 2000, 136 (5), 664-672.
-
(2000)
J. Pediatr.
, vol.136
, Issue.5
, pp. 664-672
-
-
Fagot-Campagna, A.1
Pettitt, D.J.2
Engelgau, M.M.3
Burrows, N.R.4
Geiss, L.S.5
Baldez, R.6
Beckles, G.I.7
Saaddine, J.8
Gregg, E.W.9
Williamson, D.F.10
Narayan, K.M.V.11
-
73
-
-
75849131328
-
Roles of Gastrointestinal and Adipose Tissue Peptides in Childhood Obesity and Changes after Weight Loss Due to Lifestyle Intervention
-
Roth, C.L.; Reinehr, T. Roles of Gastrointestinal and Adipose Tissue Peptides in Childhood Obesity and Changes After Weight Loss Due to Lifestyle Intervention. Arch. Pediatr. Adolesc. Med., 2010, 164 (2), 131-138.
-
(2010)
Arch. Pediatr. Adolesc. Med.
, vol.164
, Issue.2
, pp. 131-138
-
-
Roth, C.L.1
Reinehr, T.2
-
74
-
-
29244488545
-
Link between obesity and type 2 diabetes
-
Golay, A.; Ybarra, J. Link between obesity and type 2 diabetes. Best Pract. Res. Clin. Endocrinol. Metab., 2005, 19 (4), 649-663.
-
(2005)
Best Pract. Res. Clin. Endocrinol. Metab.
, vol.19
, Issue.4
, pp. 649-663
-
-
Golay, A.1
Ybarra, J.2
-
75
-
-
35348825010
-
Quinazolinone Derivatives as Orally Available Ghrelin Receptor Antagonists for the Treatment of Diabetes and Obesity
-
Rudolph, J.; Esler, W.P.; O'Connor, S.; Coish, P.D.G.; Wickens, P.L.; Brands, M.; Bierer, D.E.; Bloomquist, B.T.; Bondar, G.; Chen, L.; Chuang, C.-Y.; Claus, T.H.; Fathi, Z.; Fu, W.; Khire, U.R.; Kristie, J.A.; Liu, X.-G.; Lowe, D.B.; McClure, A.C.; Michels, M.; Ortiz, A.A.; Ramsden, P.D.; Schoenleber, R.W.; Shelekhin, T.E.; Vakalopoulos, A.; Tang, W.; Wang, L.; Yi, L.; Gardell, S.J.; Livingston, J.N.; Sweet, L.J.; Bullock, W.H. Quinazolinone Derivatives as Orally Available Ghrelin Receptor Antagonists for the Treatment of Diabetes and Obesity. J. Med. Chem., 2007, 50 (21), 5202-5216.
-
(2007)
J. Med. Chem.
, vol.50
, Issue.21
, pp. 5202-5216
-
-
Rudolph, J.1
Esler, W.P.2
O'Connor, S.3
Coish, P.D.G.4
Wickens, P.L.5
Brands, M.6
Bierer, D.E.7
Bloomquist, B.T.8
Bondar, G.9
Chen, L.10
Chuang, C.-Y.11
Claus, T.H.12
Fathi, Z.13
Fu, W.14
Khire, U.R.15
Kristie, J.A.16
Liu, X.-G.17
Lowe, D.B.18
McClure, A.C.19
Michels, M.20
Ortiz, A.A.21
Ramsden, P.D.22
Schoenleber, R.W.23
Shelekhin, T.E.24
Vakalopoulos, A.25
Tang, W.26
Wang, L.27
Yi, L.28
Gardell, S.J.29
Livingston, J.N.30
Sweet, L.J.31
Bullock, W.H.32
more..
-
76
-
-
35548949948
-
Small-Molecule Ghrelin Receptor Antagonists Improve Glucose Tolerance, Suppress Appetite, and Promote Weight Loss
-
Esler, W.P.; Rudolph, J.; Claus, T.H.; Tang, W.; Barucci, N.; Brown, S.-E.; Bullock, W.; Daly, M.; DeCarr, L.; Li, Y.; Milardo, L.; Molstad, D.; Zhu, J.; Gardell, S.J.; Livingston, J.N.; Sweet, L.J. Small-Molecule Ghrelin Receptor Antagonists Improve Glucose Tolerance, Suppress Appetite, and Promote Weight Loss. Endocrinology, 2007, 148 (11), 5175-5185.
-
(2007)
Endocrinology
, vol.148
, Issue.11
, pp. 5175-5185
-
-
Esler, W.P.1
Rudolph, J.2
Claus, T.H.3
Tang, W.4
Barucci, N.5
Brown, S.-E.6
Bullock, W.7
Daly, M.8
Decarr, L.9
Li, Y.10
Milardo, L.11
Molstad, D.12
Zhu, J.13
Gardell, S.J.14
Livingston, J.N.15
Sweet, L.J.16
-
77
-
-
0035095755
-
Blockade of the growth hormone (GH) receptor unmasks rapid GH-releasing peptide-6-mediated tissue-specific insulin resistance
-
Muller, A.F.; Janssen, J.A.; Hofland, L.J.; Lamberts, S.W.; Bidlingmaier, M.; Strasburger, C.J.; van der Lely, A.J. Blockade of the growth hormone (GH) receptor unmasks rapid GH-releasing peptide-6-mediated tissue-specific insulin resistance. J. Clin. Endocrinol. Metab., 2001, 86 (2), 590-593.
-
(2001)
J. Clin. Endocrinol. Metab.
, vol.86
, Issue.2
, pp. 590-593
-
-
Muller, A.F.1
Janssen, J.A.2
Hofland, L.J.3
Lamberts, S.W.4
Bidlingmaier, M.5
Strasburger, C.J.6
Van Der Lely, A.J.7
-
78
-
-
15644364105
-
Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure
-
Svensson, J.; Lonn, L.; Jansson, J.O.; Murphy, G.; Wyss, D.; Krupa, D.; Cerchio, K.; Polvino, W.; Gertz, B.; Boseaus, I.; Sjostrom, L.; Bengtsson, B.A. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. J. Clin. Endocrinol. Metab., 1998, 83 (2), 362-369.
-
(1998)
J. Clin. Endocrinol. Metab.
, vol.83
, Issue.2
, pp. 362-369
-
-
Svensson, J.1
Lonn, L.2
Jansson, J.O.3
Murphy, G.4
Wyss, D.5
Krupa, D.6
Cerchio, K.7
Polvino, W.8
Gertz, B.9
Boseaus, I.10
Sjostrom, L.11
Bengtsson, B.A.12
-
79
-
-
33646090850
-
2, 4-Diaminopyrimidine Derivatives as Potent Growth Hormone Secretagogue Receptor Antagonists
-
Serby, M.D.; Zhao, H.; Szczepankiewicz, B.G.; Kosogof, C.; Xin, Z.; Liu, B.; Liu, M.; Nelson, L.T.J.; Kaszubska, W.; Falls, H.D.; Schaefer, V.; Bush, E.N.; Shapiro, R.; Droz, B.A.; Knourek-Segel, V.E.; Fey, T.A.; Brune, M.E.; Beno, D.W.A.; Turner, T.M.; Collins, C.A.; Jacobson, P.B.; Sham, H.L.; Liu, G. 2, 4-Diaminopyrimidine Derivatives as Potent Growth Hormone Secretagogue Receptor Antagonists. J. Med. Chem., 2006, 49 (8), 2568-2578.
-
(2006)
J. Med. Chem.
, vol.49
, Issue.8
, pp. 2568-2578
-
-
Serby, M.D.1
Zhao, H.2
Szczepankiewicz, B.G.3
Kosogof, C.4
Xin, Z.5
Liu, B.6
Liu, M.7
Nelson, L.T.J.8
Kaszubska, W.9
Falls, H.D.10
Schaefer, V.11
Bush, E.N.12
Shapiro, R.13
Droz, B.A.14
Knourek-Segel, V.E.15
Fey, T.A.16
Brune, M.E.17
Beno, D.W.A.18
Turner, T.M.19
Collins, C.A.20
Jacobson, P.B.21
Sham, H.L.22
Liu, G.23
more..
-
80
-
-
33144468937
-
Optimization of 2, 4-diaminopyrimidines as GHS-R antagonists: Side chain exploration
-
Liu, B.; Liu, M.; Xin, Z.; Zhao, H.; Serby, M.D.; Kosogof, C.; Nelson, L.T.J.; Szczepankiewicz, B.G.; Kaszubska, W.; Schaefer, V.G.; Falls, H.D.; Lin, C.W.; Collins, C.A.; Sham, H.L.; Liu, G. Optimization of 2, 4-diaminopyrimidines as GHS-R antagonists: Side chain exploration. Bioorg. Med. Chem. Lett., 2006, 16 (7), 1864-1868.
-
(2006)
Bioorg. Med. Chem. Lett.
, vol.16
, Issue.7
, pp. 1864-1868
-
-
Liu, B.1
Liu, M.2
Xin, Z.3
Zhao, H.4
Serby, M.D.5
Kosogof, C.6
Nelson, L.T.J.7
Szczepankiewicz, B.G.8
Kaszubska, W.9
Schaefer, V.G.10
Falls, H.D.11
Lin, C.W.12
Collins, C.A.13
Sham, H.L.14
Liu, G.15
-
81
-
-
71749098026
-
Discovery and optimization of novel 4-[(aminocarbonyl)amino]-N-[4-(2- aminoethyl)phenyl]benzenesulfonamide ghrelin receptor antagonists
-
Pasternak, A.; Goble, S.D.; deJesus, R.K.; Hreniuk, D.L.; Chung, C.C.; Tota, M.R.; Mazur, P.; Feighner, S.D.; Howard, A.D.; Mills, S.G.; Yang, L. Discovery and optimization of novel 4-[(aminocarbonyl)amino]-N-[4-(2-aminoethyl) phenyl]benzenesulfonamide ghrelin receptor antagonists. Bioorg. Med. Chem. Lett., 2009, 19 (21), 6237-6240.
-
(2009)
Bioorg. Med. Chem. Lett.
, vol.19
, Issue.21
, pp. 6237-6240
-
-
Pasternak, A.1
Goble, S.D.2
Dejesus, R.K.3
Hreniuk, D.L.4
Chung, C.C.5
Tota, M.R.6
Mazur, P.7
Feighner, S.D.8
Howard, A.D.9
Mills, S.G.10
Yang, L.11
-
82
-
-
0026021161
-
Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
-
DeFronzo, R.A.; Ferrannini, E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 1991, 14 (3), 173-194.
-
(1991)
Diabetes Care
, vol.14
, Issue.3
, pp. 173-194
-
-
Defronzo, R.A.1
Ferrannini, E.2
-
83
-
-
0024511329
-
Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM
-
Consoli, A.; Nurjhan, N.; Capani, F.; Gerich, J. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes, 1989, 38 (5), 550-557.
-
(1989)
Diabetes
, vol.38
, Issue.5
, pp. 550-557
-
-
Consoli, A.1
Nurjhan, N.2
Capani, F.3
Gerich, J.4
-
84
-
-
0019935881
-
Rapid changes in the concentration of phosphoenolpyruvate carboxykinase mRNA in rat liver and kidney. Effects of insulin and cyclic AMP
-
Cimbala, A.N.; Lamers, W.H.; Nelson, J.E.; Monahan, J.E.; Yoo-Warren, H.; Hanson, R.W. Rapid changes in the concentration of phosphoenolpyruvate carboxykinase mRNA in rat liver and kidney. Effects of insulin and cyclic AMP. J. Biol. Chem., 1982, 257 (13), 7629-7636.
-
(1982)
J. Biol. Chem.
, vol.257
, Issue.13
, pp. 7629-7636
-
-
Cimbala, A.N.1
Lamers, W.H.2
Nelson, J.E.3
Monahan, J.E.4
Yoo-Warren, H.5
Hanson, R.W.6
-
85
-
-
0242687126
-
Parasite Mitochondria as Drug Target: Diversity and Dynamic Changes during the Life Cycle
-
Kita, K.; Nihei, C.; Tomitsuka, E. Parasite Mitochondria as Drug Target: Diversity and Dynamic Changes During the Life Cycle. Curr. Med. Chem., 2003, 10 (23), 2535-2548.
-
(2003)
Curr. Med. Chem.
, vol.10
, Issue.23
, pp. 2535-2548
-
-
Kita, K.1
Nihei, C.2
Tomitsuka, E.3
-
86
-
-
0037163021
-
The key role of anaplerosis and cataplerosis for citric acid cycle function
-
Owen, O.E.; Kalhan, S.C.; and Hanson, R.W. The key role of anaplerosis and cataplerosis for citric acid cycle function. J. Biol. Chem., 2002, 277 (34), 30409-30412.
-
(2002)
J. Biol. Chem.
, vol.277
, Issue.34
, pp. 30409-30412
-
-
Owen, O.E.1
Kalhan, S.C.2
Hanson, R.W.3
-
87
-
-
0034826624
-
Mechanism of increased renal gene expression during metabolic acidosis
-
Curthoys, N.P.; Gstraunthaler, G. Mechanism of increased renal gene expression during metabolic acidosis. Am. J. Physiol. Renal Physiol., 2001, 281 (3), F381-F390.
-
(2001)
Am. J. Physiol. Renal Physiol.
, vol.281
, Issue.3
-
-
Curthoys, N.P.1
Gstraunthaler, G.2
-
88
-
-
0035088022
-
Rat small intestine is an insulin-sensitive gluconeogenic organ
-
Croset, M.; Rajas, F.; Zitoun, C.; Hurot, J.M.; Montano, S.; Mithieux, G. Rat small intestine is an insulin-sensitive gluconeogenic organ. Diabetes, 2001, 50 (4), 740-746.
-
(2001)
Diabetes
, vol.50
, Issue.4
, pp. 740-746
-
-
Croset, M.1
Rajas, F.2
Zitoun, C.3
Hurot, J.M.4
Montano, S.5
Mithieux, G.6
-
89
-
-
30344450829
-
Overcoming Diabetes-Induced Hyperglycemia through Inhibition of Hepatic Phosphoenolpyruvate Carboxykinase (GTP) with RNAi
-
Gómez-Valadés, A.G.; Vidal-Alabró, A.; Molas, M.; Boada, J.; Bermúdez, J.; Bartrons, R.; Perales, J.C. Overcoming Diabetes-Induced Hyperglycemia through Inhibition of Hepatic Phosphoenolpyruvate Carboxykinase (GTP) with RNAi. Mol. Ther., 2006, 13 (2), 401-410.
-
(2006)
Mol. Ther.
, vol.13
, Issue.2
, pp. 401-410
-
-
Gómez-Valadés, A.G.1
Vidal-Alabró, A.2
Molas, M.3
Boada, J.4
Bermúdez, J.5
Bartrons, R.6
Perales, J.C.7
-
90
-
-
0030998776
-
Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression
-
Hanson, R.W.; Reshef, L. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu. Rev. Biochem., 1997, 66 (1), 581-611.
-
(1997)
Annu. Rev. Biochem.
, vol.66
, Issue.1
, pp. 581-611
-
-
Hanson, R.W.1
Reshef, L.2
-
91
-
-
0141786821
-
Modified 3-Alkyl-1, 8-dibenzylxanthines as GTP-Competitive inhibitors of phosphoenolpyruvate carboxykinase
-
Foley, L.H.; Wang, P.; Dunten, P.; Ramsey, G.; Gubler, M.-L.; Wertheimer, S.J. Modified 3-Alkyl-1, 8-dibenzylxanthines as GTP-Competitive inhibitors of phosphoenolpyruvate carboxykinase. Bioorg. Med. Chem. Lett., 2003, 13 (20), 3607-3610.
-
(2003)
Bioorg. Med. Chem. Lett.
, vol.13
, Issue.20
, pp. 3607-3610
-
-
Foley, L.H.1
Wang, P.2
Dunten, P.3
Ramsey, G.4
Gubler, M.-L.5
Wertheimer, S.J.6
-
92
-
-
0141545054
-
X-ray Structures of two xanthine inhibitors bound to PEPCK and N-3 modifications of substituted 1, 8-Dibenzylxanthines
-
Foley, L.H.; Wang, P.; Dunten, P.; Ramsey, G.; Gubler, M.-L.; Wertheimer, S.J. X-ray Structures of two xanthine inhibitors bound to PEPCK and N-3 modifications of substituted 1, 8-Dibenzylxanthines. Bioorg. Med. Chem. Lett., 2003, 13 (21), 3871-3874.
-
(2003)
Bioorg. Med. Chem. Lett.
, vol.13
, Issue.21
, pp. 3871-3874
-
-
Foley, L.H.1
Wang, P.2
Dunten, P.3
Ramsey, G.4
Gubler, M.-L.5
Wertheimer, S.J.6
-
93
-
-
34250363033
-
C-8 Modifications of 3-alkyl-1, 8-dibenzylxanthines as inhibitors of human cytosolic phosphoenolpyruvate carboxykinase
-
Pietranico, S.L.; Foley, L.H.; Huby, N.; Yun, W.; Dunten, P.; Vermeulen, J.; Wang, P.; Toth, K.; Ramsey, G.; Gubler, M.-L.; Wertheimer, S.J. C-8 Modifications of 3-alkyl-1, 8-dibenzylxanthines as inhibitors of human cytosolic phosphoenolpyruvate carboxykinase. Bioorg. Med. Chem. Lett., 2007, 17 (14), 3835-3839.
-
(2007)
Bioorg. Med. Chem. Lett.
, vol.17
, Issue.14
, pp. 3835-3839
-
-
Pietranico, S.L.1
Foley, L.H.2
Huby, N.3
Yun, W.4
Dunten, P.5
Vermeulen, J.6
Wang, P.7
Toth, K.8
Ramsey, G.9
Gubler, M.-L.10
Wertheimer, S.J.11
-
94
-
-
0024839184
-
Banting lecture 1989. Structure and function of insulin receptors
-
Rosen, O.M. Banting lecture 1989. Structure and function of insulin receptors. Diabetes, 1989, 38 (12), 1508-1511.
-
(1989)
Diabetes
, vol.38
, Issue.12
, pp. 1508-1511
-
-
Rosen, O.M.1
-
95
-
-
37249047933
-
Structural insights into ligand-induced activation of the insulin receptor
-
Ward, C.; Lawrence, M.; Streltsov, V.; Garrett, T.; McKern, N.; Lou, M.Z.; Lovrecz, G.; Adams, T. Structural insights into ligand-induced activation of the insulin receptor. Acta Physiol. (Oxford) 2008, 192 (1), 3-9.
-
(2008)
Acta Physiol. (Oxford)
, vol.192
, Issue.1
, pp. 3-9
-
-
Ward, C.1
Lawrence, M.2
Streltsov, V.3
Garrett, T.4
McKern, N.5
Lou, M.Z.6
Lovrecz, G.7
Adams, T.8
-
96
-
-
0025945012
-
Insulin resistance-mechanisms, syndromes, and implications
-
Moller, D.E.; Flier, J.S. Insulin resistance-mechanisms, syndromes, and implications. N. Engl. J. Med., 1991, 325 (13), 938-948.
-
(1991)
N. Engl. J. Med.
, vol.325
, Issue.13
, pp. 938-948
-
-
Moller, D.E.1
Flier, J.S.2
-
97
-
-
0027953703
-
Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes
-
Kahn, C.R. Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes, 1994, 43 (8), 1066-1084.
-
(1994)
Diabetes
, vol.43
, Issue.8
, pp. 1066-1084
-
-
Kahn, C.R.1
-
98
-
-
33845432866
-
Regulating insulin signaling and beta-cell function through IRS proteins
-
White, M.F. Regulating insulin signaling and beta-cell function through IRS proteins. Can. J. Physiol. Pharmacol., 2006, 84 (7), 725-737.
-
(2006)
Can. J. Physiol. Pharmacol.
, vol.84
, Issue.7
, pp. 725-737
-
-
White, M.F.1
-
99
-
-
0031939124
-
Insulin receptor internalization and signalling
-
Di Guglielmo, G.M.; Drake, P.G.; Baass, P.C.; Authier, F.; Posner, B.I.; Bergeron, J.J. Insulin receptor internalization and signalling. Mol. Cell. Biochem., 1998, 182 (1-2), 59-63.
-
(1998)
Mol. Cell. Biochem.
, vol.182
, Issue.1-2
, pp. 59-63
-
-
Di Guglielmo, G.M.1
Drake, P.G.2
Baass, P.C.3
Authier, F.4
Posner, B.I.5
Bergeron, J.J.6
-
100
-
-
0035081517
-
A novel small molecule that directly sensitizes the insulin receptor in Vitro and in Vi Vo
-
Manchem, V.P.; Goldfine, I.D.; Kohanski, R.A.; Cristobal, C.P.; Lum, R.T.; Schow, S.R.; Shi, S.; Spevak, W.R.; Laborde, E.; Toavs, D.K.; Villar, H.O.; Wick, M.M.; Kozlowski, M.R. A novel small molecule that directly sensitizes the insulin receptor in Vitro and in Vi Vo. Diabetes, 2001, 50 (4), 824-830.
-
(2001)
Diabetes
, vol.50
, Issue.4
, pp. 824-830
-
-
Manchem, V.P.1
Goldfine, I.D.2
Kohanski, R.A.3
Cristobal, C.P.4
Lum, R.T.5
Schow, S.R.6
Shi, S.7
Spevak, W.R.8
Laborde, E.9
Toavs, D.K.10
Villar, H.O.11
Wick, M.M.12
Kozlowski, M.R.13
-
101
-
-
33947596679
-
The GLUT4 glucose transporter
-
Huang, S.; Czech, M.P. The GLUT4 glucose transporter. Cell Metab., 2007, 5 (4), 237-252.
-
(2007)
Cell Metab.
, vol.5
, Issue.4
, pp. 237-252
-
-
Huang, S.1
Czech, M.P.2
-
102
-
-
13344277357
-
Early neonatal death in mice homozygous for a null allele of the insulin receptor gene
-
Accili, D.; Drago, J.; Lee, E.J.; Johnson, M.D.; Cool, M.H.; Salvatore, P.; Asico, L.D.; Jose, P.A.; Taylor, S.; Westphal, H. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat. Genet, 1996, 12 (1), 106-109.
-
(1996)
Nat. Genet
, vol.12
, Issue.1
, pp. 106-109
-
-
Accili, D.1
Drago, J.2
Lee, E.J.3
Johnson, M.D.4
Cool, M.H.5
Salvatore, P.6
Asico, L.D.7
Jose, P.A.8
Taylor, S.9
Westphal, H.10
-
103
-
-
0036433407
-
Small Molecule Activators of the Insulin Receptor: Potential New Therapeutic Agents for the Treatment of Diabetes Mellitus
-
Laborde, E.; Manchem, V.P. Small Molecule Activators of the Insulin Receptor: Potential New Therapeutic Agents for the Treatment of Diabetes Mellitus. Curr. Med. Chem., 2002, 9 (24), 2231.
-
(2002)
Curr. Med. Chem.
, vol.9
, Issue.24
, pp. 2231
-
-
Laborde, E.1
Manchem, V.P.2
-
104
-
-
0037113863
-
Regulation of Insulin Receptor Function by a Small Moleculen Insulin Receptor Activator
-
Pender, C; Goldfine, I.D.; Manchem, V.P.; Evans, J.L.; Spevak, W.R.; Shi, S.; Rao, S.; Bajjalieh, S.; Maddux, B.A.; Youngren, J.F. Regulation of Insulin Receptor Function by a Small Moleculen Insulin Receptor Activator. J. Biol. Chem., 2002, 277 (46), 43565-43571.
-
(2002)
J. Biol. Chem.
, vol.277
, Issue.46
, pp. 43565-43571
-
-
Pender, C.1
Goldfine, I.D.2
Manchem, V.P.3
Evans, J.L.4
Spevak, W.R.5
Shi, S.6
Rao, S.7
Bajjalieh, S.8
Maddux, B.A.9
Youngren, J.F.10
-
105
-
-
53549121997
-
Design, Synthesis, and Structure-Activity Relationships of Novel Insulin Receptor Tyrosine Kinase Activators
-
Lum, R.T.; Cheng, M.; Cristobal, C.P; Goldfine, I.D.; Evans, J.L.; Keck, J.G.; Macsata, R.W.; Manchem, V.P; Matsumoto, Y.; Park, S.J.; Rao, S.S.; Robinson, L.; Shi, S.; Spevak, W.R.; Schow, S.R. Design, Synthesis, and Structure-Activity Relationships of Novel Insulin Receptor Tyrosine Kinase Activators. J. Med. Chem., 2008, 51 (19), 6173-6187.
-
(2008)
J. Med. Chem.
, vol.51
, Issue.19
, pp. 6173-6187
-
-
Lum, R.T.1
Cheng, M.2
Cristobal, C.P.3
Goldfine, I.D.4
Evans, J.L.5
Keck, J.G.6
MacSata, R.W.7
Manchem, V.P.8
Matsumoto, Y.9
Park, S.J.10
Rao, S.S.11
Robinson, L.12
Shi, S.13
Spevak, W.R.14
Schow, S.R.15
-
106
-
-
4444289382
-
Negative glucocorticoid receptor response elements and their role in glucocorticoid action
-
Dostert, A.; Heinzel, T. Negative glucocorticoid receptor response elements and their role in glucocorticoid action. Curr. Pharm. Des., 2004, 10 (23), 2807-2816.
-
(2004)
Curr. Pharm. Des.
, vol.10
, Issue.23
, pp. 2807-2816
-
-
Dostert, A.1
Heinzel, T.2
-
107
-
-
0021356212
-
Hormonal regulation of hepatic gluconeogenesis
-
Kraus-Friedmann, N. Hormonal regulation of hepatic gluconeogenesis. Physiol. Rev., 1984, 64 (1), 170-259.
-
(1984)
Physiol. Rev.
, vol.64
, Issue.1
, pp. 170-259
-
-
Kraus-Friedmann, N.1
-
108
-
-
0033617150
-
Transcriptional repression of pref-1 by glucocorticoids promotes 3T3-L1 adipocyte differentiation
-
Smas, CM.; Chen, L.; Zhao, L.; Latasa, M.J.; Sul, H.S. Transcriptional repression of pref-1 by glucocorticoids promotes 3T3-L1 adipocyte differentiation. J. Biol. Chem., 1999, 274 (18), 12632-12641.
-
(1999)
J. Biol. Chem.
, vol.274
, Issue.18
, pp. 12632-12641
-
-
Smas, C.M.1
Chen, L.2
Zhao, L.3
Latasa, M.J.4
Sul, H.S.5
-
109
-
-
0035824440
-
A transgenic model of visceral obesity and the metabolic syndrome
-
Masuzaki, H.; Paterson, J.; Shinyama, H.; Morton, N.M.; Mullins, J. J.; Seckl, J.R.; Flier, J.S. A transgenic model of visceral obesity and the metabolic syndrome. Science, 2001, 294 (5549), 2166-2170.
-
(2001)
Science
, vol.294
, Issue.5549
, pp. 2166-2170
-
-
Masuzaki, H.1
Paterson, J.2
Shinyama, H.3
Morton, N.M.4
Mullins, J.J.5
Seckl, J.R.6
Flier, J.S.7
-
110
-
-
0035656177
-
Pathophysiology of modulation of local glucocorticoid levels by 11beta-hydroxysteroid dehydrogenases
-
Sandeep, T.C.; Walker, B.R. Pathophysiology of modulation of local glucocorticoid levels by 11beta-hydroxysteroid dehydrogenases. Trends in Endocrinol. Metab., 2001, 12 (10), 446-453.
-
(2001)
Trends in Endocrinol. Metab.
, vol.12
, Issue.10
, pp. 446-453
-
-
Sandeep, T.C.1
Walker, B.R.2
-
111
-
-
0028034209
-
Cloning and tissue distribution of the human 11 ß-hydroxysteroid dehydrogenase type 2 enzyme
-
Albiston, A.L.; Obeyesekere, V.R.; Smith, R.E.; Krozowski, Z.S. Cloning and tissue distribution of the human 11 ß-hydroxysteroid dehydrogenase type 2 enzyme. Mol. Cell. Endocrin., 1994, 105 (1), 11-17.
-
(1994)
Mol. Cell. Endocrin.
, vol.105
, Issue.1
, pp. 11-17
-
-
Albiston, A.L.1
Obeyesekere, V.R.2
Smith, R.E.3
Krozowski, Z.S.4
-
112
-
-
61849114268
-
Glucocorticoids, 11beta-hydroxyster oid dehydrogenase: Mother, fetus, or both?
-
Challis, J.R.; Connor, K. Glucocorticoids, 11beta-hydroxyster oid dehydrogenase: mother, fetus, or both? Endocrinology, 2009, 150 (3), 1073-1074.
-
(2009)
Endocrinology
, vol.150
, Issue.3
, pp. 1073-1074
-
-
Challis, J.R.1
Connor, K.2
-
113
-
-
4043077286
-
11beta-hydroxyster oid dehydrogenase type 1: A tissue-specific regulator of glucocorticoid response
-
Tomlinson, J.W.; Walker, E.A.; Bujalska, I.J.; Draper, N; Lavery, G.G.; Cooper, M. S.; Hewison, M.; Stewart, P.M. 11beta-hydroxyster oid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr. Rev., 2004, 25 (5), 831-866.
-
(2004)
Endocr. Rev.
, vol.25
, Issue.5
, pp. 831-866
-
-
Tomlinson, J.W.1
Walker, E.A.2
Bujalska, I.J.3
Draper, N.4
Lavery, G.G.5
Cooper, M.S.6
Hewison, M.7
Stewart, P.M.8
-
114
-
-
0031046241
-
11 beta-Hydro xyster o id dehydrogenase and the syndrome of apparent mineralocorticoid excess
-
White, P. C.; Mune, T.; Agarwal, A.K. 11 beta-Hydro xyster o id dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr. Rev, 1997, 18 (1), 135-136.
-
(1997)
Endocr. Rev
, vol.18
, Issue.1
, pp. 135-136
-
-
White, P.C.1
Mune, T.2
Agarwal, A.K.3
-
115
-
-
2342510149
-
Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice
-
Paterson, J.M.; Morton, N.M.; Fievet, C; Kenyon, C.J.; Holmes, M.C.; Staels, B.; Seckl, J.R.; Mullins, J.J. Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc. Natl. Acad. Sci. U.S.A., 2004, 101 (18), 7088-7093.
-
(2004)
Proc. Natl. Acad. Sci. U.S.A.
, vol.101
, Issue.18
, pp. 7088-7093
-
-
Paterson, J.M.1
Morton, N.M.2
Fievet, C.3
Kenyon, C.J.4
Holmes, M.C.5
Staels, B.6
Seckl, J.R.7
Mullins, J.J.8
-
116
-
-
12144291638
-
Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice
-
Morton, N.M.; Paterson, J.M.; Masuzaki, H.; Holmes, M.C.; Staels, B.; Fievet, C; Walker, B.R.; Flier, J.S.; Mullins, J.J.; Seckl, J.R. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes, 2004, 53 (4), 931-938.
-
(2004)
Diabetes
, vol.53
, Issue.4
, pp. 931-938
-
-
Morton, N.M.1
Paterson, J.M.2
Masuzaki, H.3
Holmes, M.C.4
Staels, B.5
Fievet, C.6
Walker, B.R.7
Flier, J.S.8
Mullins, J.J.9
Seckl, J.R.10
-
117
-
-
0031283178
-
1 1beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress
-
Kotelevtsev, Y; Holmes, M.C.; Burchell, A.; Houston, P.M.; Schmoll, D.; Jamieson, P.; Best, R.; Brown, R.; Edwards, C.R.W.; Seckl, J.R.; Mullins, J.J. 1 1beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc. Natl. Acad. Sci. U.S.A., 1997, 94 (26), 14924-14929.
-
(1997)
Proc. Natl. Acad. Sci. U.S.A.
, vol.94
, Issue.26
, pp. 14924-14929
-
-
Kotelevtsev, Y.1
Holmes, M.C.2
Burchell, A.3
Houston, P.M.4
Schmoll, D.5
Jamieson, P.6
Best, R.7
Brown, R.8
Edwards, C.R.W.9
Seckl, J.R.10
Mullins, J.J.11
-
118
-
-
59149094004
-
Inhibitors of 11beta-HSD1: A potential treatment for the metabolic syndrome
-
St Jean, D.J.; Wang, M.; Fotsch, C. Inhibitors of 11beta-HSD1: a potential treatment for the metabolic syndrome. Curr. Top. Med. Chem., 2008, 8 (17), 1508-1523.
-
(2008)
Curr. Top. Med. Chem.
, vol.8
, Issue.17
, pp. 1508-1523
-
-
St Jean, D.J.1
Wang, M.2
Fotsch, C.3
-
119
-
-
34447105433
-
Inhibition of 11beta-hydroxy steroid dehydrogenase type 1 as a promising therapeutic target
-
Wamil, M.; Seckl, J.R. Inhibition of 11beta-hydroxy steroid dehydrogenase type 1 as a promising therapeutic target. Drug Discov. Today, 2007, 12 (13-14), 504-520.
-
(2007)
Drug Discov. Today
, vol.12
, Issue.13-14
, pp. 504-520
-
-
Wamil, M.1
Seckl, J.R.2
-
120
-
-
46749112663
-
Development of 11beta-HSD1 inhibitors for the treatment of type 2 diabetes
-
Hale, C; Wang, M. Development of 11beta-HSD1 inhibitors for the treatment of type 2 diabetes. Mini. Rev. Med. Chem., 2008, 8 (7), 702-710.
-
(2008)
Mini. Rev. Med. Chem.
, vol.8
, Issue.7
, pp. 702-710
-
-
Hale, C.1
Wang, M.2
-
121
-
-
77950664531
-
11-beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors as Promising Therapeutic Drugs for Diabetes: Status and Development
-
Ge, R.; Huang, Y; Liang, G.; Li, X. 11-beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors as Promising Therapeutic Drugs for Diabetes: Status and Development. Curr. Med. Chem., 2010, 17 (5), 412-422.
-
(2010)
Curr. Med. Chem.
, vol.17
, Issue.5
, pp. 412-422
-
-
Ge, R.1
Huang, Y.2
Liang, G.3
Li, X.4
-
122
-
-
0037194658
-
Arylsulfonamidothiazoles as a New Class of Potential Antidiabetic Drugs. Discovery of Potent and Selective Inhibitors of the 11 ß-Hydroxysteroid Dehydrogenase Type 1
-
Barf, T; Vallgårda, J.; Emond, R.; Ha ggstro m, C; Kurz, G.; Nygren, A.; Larwood, V; Mosialou, E.; Axelsson, K.; Olsson, R.; Engblom, L.; Edling, N; Ro nquist-Nii, Y; O hman, B.; Alberts, P.; Abrahmsen, L. Arylsulfonamidothiazoles as a New Class of Potential Antidiabetic Drugs. Discovery of Potent and Selective Inhibitors of the 11 ß-Hydroxysteroid Dehydrogenase Type 1. J. Med. Chem., 2002, 45 (18), 3813-3815.
-
(2002)
J. Med. Chem.
, vol.45
, Issue.18
, pp. 3813-3815
-
-
Barf, T.1
Vallgårda, J.2
Emond, R.3
Haggstrom, C.4
Kurz, G.5
Nygren, A.6
Larwood, V.7
Mosialou, E.8
Axelsson, K.9
Olsson, R.10
Engblom, L.11
Edling, N.12
Ronquist-Nii, Y.13
Hman B, O.14
Alberts, P.15
Abrahmsen, L.16
-
123
-
-
0036432995
-
Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice
-
Alberts, P.; Engblom, L.; Edling, N; Forsgren, M.; Klingstrom, G.; Larsson, C; Ronquist-Nii, Y; Ohman, B.; Abrahmsen, L. Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia, 2002, 45 (11), 1528-1532.
-
(2002)
Diabetologia
, vol.45
, Issue.11
, pp. 1528-1532
-
-
Alberts, P.1
Engblom, L.2
Edling, N.3
Forsgren, M.4
Klingstrom, G.5
Larsson, C.6
Ronquist-Nii, Y.7
Ohman, B.8
Abrahmsen, L.9
-
124
-
-
0242468543
-
Selective inhibition of 11 betahydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains
-
Alberts, P.; Nilsson, C; Selen, G.; Engblom, L.O.; Edling, N.H.; Norling, S.; Klingstrom, G.; Larsson, C; Forsgren, M.; Ashkzari, M.; Nilsson, CE.; Fiedler, M.; Bergqvist, E.; Ohman, B.; Bjorkstrand, E.; Abrahmsen, L.B. Selective inhibition of 11 betahydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology, 2003, 144 (11), 4755-4762.
-
(2003)
Endocrinology
, vol.144
, Issue.11
, pp. 4755-4762
-
-
Alberts, P.1
Nilsson, C.2
Selen, G.3
Engblom, L.O.4
Edling, N.H.5
Norling, S.6
Klingstrom, G.7
Larsson, C.8
Forsgren, M.9
Ashkzari, M.10
Nilsson, C.E.11
Fiedler, M.12
Bergqvist, E.13
Ohman, B.14
Bjorkstrand, E.15
Abrahmsen, L.B.16
-
125
-
-
21144456678
-
Synthesis and biological evaluation of sulfonamidooxazoles and ß-keto sulfones: Selective inhibitors of 11 ß-hydroxysteroid dehydrogenase type i
-
Xiang, J.; Ipek, M.; Suri, V; Massefski, W.; Pan, N; Ge, Y; Tam, M.; Xing, Y.; Tobin, J.F.; Xu, X. Synthesis and biological evaluation of sulfonamidooxazoles and ß-keto sulfones: selective inhibitors of 11 ß-hydroxysteroid dehydrogenase type I. Bioorg. Med. Chem. Lett, 2005, 15 (11), 2865-2869.
-
(2005)
Bioorg. Med. Chem. Lett
, vol.15
, Issue.11
, pp. 2865-2869
-
-
Xiang, J.1
Ipek, M.2
Suri, V.3
Massefski, W.4
Pan, N.5
Ge, Y.6
Tam, M.7
Xing, Y.8
Tobin, J.F.9
Xu, X.10
-
126
-
-
34248655920
-
Keto sulfones as inhibitors of 11-hydroxysteroid dehydrogenase type I and the mechanism of action
-
Xiang, J.; Ipek, M.; Suri, V.; Tam, M.; Xing, Y.; Huang, N; Zhang, Y; Tobin, J.; Mansour, T.S.; McKew, J. Keto sulfones as inhibitors of 11-hydroxysteroid dehydrogenase type I and the mechanism of action. Bioorg. Med. Chem., 2007, 15 (13), 4396-4405.
-
(2007)
Bioorg. Med. Chem.
, vol.15
, Issue.13
, pp. 4396-4405
-
-
Xiang, J.1
Ipek, M.2
Suri, V.3
Tam, M.4
Xing, Y.5
Huang, N.6
Zhang, Y.7
Tobin, J.8
Mansour, T.S.9
McKew, J.10
-
127
-
-
34247132757
-
Assay optimization and kinetic profile of the human and the rabbit isoforms of 11beta-HSD1
-
Castro, A.; Zhu, J.X.; Alton, G.R.; Rejto, P.; Ermolieff, J. Assay optimization and kinetic profile of the human and the rabbit isoforms of 11beta-HSD1. Biochem. Biophys. Res. Commun., 2007, 357 (2), 561-566.
-
(2007)
Biochem. Biophys. Res. Commun.
, vol.357
, Issue.2
, pp. 561-566
-
-
Castro, A.1
Zhu, J.X.2
Alton, G.R.3
Rejto, P.4
Ermolieff, J.5
-
128
-
-
66749093622
-
N-(Pyridin-2-yl) arylsulfonamide inhibitors of 11[beta]-hydroxysteroid dehydrogenase type 1: Discovery of PF-915275
-
Siu, M.; Johnson, TO.; Wang, Y; Nair, S.K.; Taylor, W.D.; Cripps, S.J.; Matthews, J.J.; Edwards, M.P.; Pauly, T.A.; Ermolieff, J.; Castro, A.; Hosea, N. A.; LaPaglia, A.; Fanjul, A.N.; Vogel, J.E. N-(Pyridin-2-yl) arylsulfonamide inhibitors of 11[beta]-hydroxysteroid dehydrogenase type 1: Discovery of PF-915275. Bioorg. Med. Chem. Lett, 2009, 19 (13), 3493-3497.
-
(2009)
Bioorg. Med. Chem. Lett
, vol.19
, Issue.13
, pp. 3493-3497
-
-
Siu, M.1
Johnson, T.O.2
Wang, Y.3
Nair, S.K.4
Taylor, W.D.5
Cripps, S.J.6
Matthews, J.J.7
Edwards, M.P.8
Pauly, T.A.9
Ermolieff, J.10
Castro, A.11
Hosea, N.A.12
Lapaglia, A.13
Fanjul, A.N.14
Vogel, J.E.15
-
129
-
-
50249091534
-
Blockade of Glucocorticoid Excess at the Tissue Level: Inhibitors of 11 ß-Hydroxysteroid Dehydrogenase Type 1 as a Therapy for Type 2 Diabetes
-
Fotsch, C; Wang, M. Blockade of Glucocorticoid Excess at the Tissue Level: Inhibitors of 11 ß-Hydroxysteroid Dehydrogenase Type 1 as a Therapy for Type 2 Diabetes. J. Med. Chem., 2008, 51 (16), 4851-4857.
-
(2008)
J. Med. Chem.
, vol.51
, Issue.16
, pp. 4851-4857
-
-
Fotsch, C.1
Wang, M.2
-
130
-
-
44649157620
-
Discovery and Initial SAR of Arylsulfonylpiperazine Inhibitors of 11[beta]-Hydroxysteroid Dehydrogenase Type 1 (11[beta]-HSD1)
-
Sun, D.; Wang, Z.; Di, Y; Jaen, J.C.; Labelle, M.; Ma, J.; Miao, S.; Sudom, A.; Tang, L.; Tomooka, CS.; Tu, H.; Ursu, S.; Walker, N; Yan, X.; Ye, Q.; Powers, J. P. Discovery and Initial SAR of Arylsulfonylpiperazine Inhibitors of 11[beta]-Hydroxysteroid Dehydrogenase Type 1 (11[beta]-HSD1). Bioorg. Med. Chem. Lett, 2008, 18 (12), 3513-3516.
-
(2008)
Bioorg. Med. Chem. Lett
, vol.18
, Issue.12
, pp. 3513-3516
-
-
Sun, D.1
Wang, Z.2
Di, Y.3
Jaen, J.C.4
Labelle, M.5
Ma, J.6
Miao, S.7
Sudom, A.8
Tang, L.9
Tomooka, C.S.10
Tu, H.11
Ursu, S.12
Walker, N.13
Yan, X.14
Ye, Q.15
Powers, J.P.16
-
131
-
-
52949108814
-
Distinctive molecular inhibition mechanisms for selective inhibitors of human 11 ß-hydroxysteroid dehydrogenase type 1
-
Tu, H.; Powers, J.P; Liu, J.; Ursu, S.; Sudom, A.; Yan, X.; Xu, H.; Meininger, D.; DeGraffenreid, M.; He, X. Distinctive molecular inhibition mechanisms for selective inhibitors of human 11 ß-hydroxysteroid dehydrogenase type 1. Bioorg. Med. Chem., 2008, 16 (19), 8922-8931.
-
(2008)
Bioorg. Med. Chem.
, vol.16
, Issue.19
, pp. 8922-8931
-
-
Tu, H.1
Powers, J.P.2
Liu, J.3
Ursu, S.4
Sudom, A.5
Yan, X.6
Xu, H.7
Meininger, D.8
Degraffenreid, M.9
He, X.10
-
132
-
-
47749122576
-
Piperazine Sulfonamides as Potent, Selective, and Orally Available 11 ß-Hydroxysteroid Dehydrogenase Type 1 Inhibitors with Efficacy in the Rat Cortisone-Induced Hyp er insulin emia Model
-
Xiang, J.; Wan, Z.-K.; Li, H.-Q.; Ipek, M.; Binnun, E.; Nunez, J.; Chen, L.; McKew, J.C.; Mansour, T.S.; Xu, X.; Suri, V.; Tam, M.; Xing, Y; Li, X.; Hahm, S.; Tobin, J.; Saiah, E. Piperazine Sulfonamides as Potent, Selective, and Orally Available 11 ß-Hydroxysteroid Dehydrogenase Type 1 Inhibitors with Efficacy in the Rat Cortisone-Induced Hyp er insulin emia Model. J. Med. Chem., 2008, 51 (14), 4068-4071.
-
(2008)
J. Med. Chem.
, vol.51
, Issue.14
, pp. 4068-4071
-
-
Xiang, J.1
Wan, Z.-K.2
Li, H.-Q.3
Ipek, M.4
Binnun, E.5
Nunez, J.6
Chen, L.7
McKew, J.C.8
Mansour, T.S.9
Xu, X.10
Suri, V.11
Tam, M.12
Xing, Y.13
Li, X.14
Hahm, S.15
Tobin, J.16
Saiah, E.17
-
133
-
-
69949107020
-
Efficacious 11 ß-Hydroxysteroid Dehydrogenase Type i Inhibitors in the Diet-Induced Obesity Mouse Model
-
Wan, Z.-K.; Chenail, E.; Xiang, J.; Li, H.-Q.; Ipek, M.; Bard, J.; Svenson, K.; Mansour, T.S.; Xu, X.; Tian, X.; Suri, V.; Hahm, S.; Xing, Y; Johnson, CE.; Li, X.; Qadri, A.; Panza, D.; Perreault, M.; Tobin, J.F; Saiah, E. Efficacious 11 ß-Hydroxysteroid Dehydrogenase Type I Inhibitors in the Diet-Induced Obesity Mouse Model. J. Med. Chem., 2009, 52 (17), 5449-5461.
-
(2009)
J. Med. Chem.
, vol.52
, Issue.17
, pp. 5449-5461
-
-
Wan, Z.-K.1
Chenail, E.2
Xiang, J.3
Li, H.-Q.4
Ipek, M.5
Bard, J.6
Svenson, K.7
Mansour, T.S.8
Xu, X.9
Tian, X.10
Suri, V.11
Hahm, S.12
Xing, Y.13
Johnson, C.E.14
Li, X.15
Qadri, A.16
Panza, D.17
Perreault, M.18
Tobin, J.F.19
Saiah, E.20
more..
-
134
-
-
60849135109
-
Structure-based virtual screening for identification of novel
-
Yang, H. Y; Shen, Y; Chen, J.H.; Jiang, Q. F.; Leng, Y; Shen, J.H. Structure-based virtual screening for identification of novel 11ß-HSD1 inhibitors. Eur. J. Med. Chem., 2009, 44 (3), 1167-1171.
-
(2009)
Eur. J. Med. Chem.
, vol.44
, Issue.3
, pp. 1167-1171
-
-
Yang, H.Y.1
Shen, Y.2
Chen, J.H.3
Jiang, Q.F.4
Leng, Y.5
Shen, J.H.6
-
135
-
-
67650178262
-
4-(Phenylsulfonamidomethyl)benzamides as potent and selective inhibitors of the 11[beta]-hydroxysteroid dehydrogenase type 1 with efficacy in diabetic ob/ob mice
-
Zhang, X.; Zhou, Z.; Yang, H.; Chen, J.; Feng, Y; Du, L.; Leng, Y; Shen, J. 4-(Phenylsulfonamidomethyl)benzamides as potent and selective inhibitors of the 11[beta]-hydroxysteroid dehydrogenase type 1 with efficacy in diabetic ob/ob mice. Bioorg. Med. Chem. Lett, 2009, 19 (15), 4455-4458.
-
(2009)
Bioorg. Med. Chem. Lett
, vol.19
, Issue.15
, pp. 4455-4458
-
-
Zhang, X.1
Zhou, Z.2
Yang, H.3
Chen, J.4
Feng, Y.5
Du, L.6
Leng, Y.7
Shen, J.8
-
136
-
-
33644916083
-
Benzothiazole derivatives as novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1
-
Su, X.; Vicker, N; Ganeshapillai, D.; Smith, A.; Purohit, A.; Reed, M.J.; Potter, B.V. Benzothiazole derivatives as novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1. Mol. Cell. Endocrinol, 2006, 248 (1-2), 214-217.
-
(2006)
Mol. Cell. Endocrinol
, vol.248
, Issue.1-2
, pp. 214-217
-
-
Su, X.1
Vicker, N.2
Ganeshapillai, D.3
Smith, A.4
Purohit, A.5
Reed, M.J.6
Potter, B.V.7
-
137
-
-
43049119332
-
Antidiabetic activity of N-(6-substituted-1, 3-benzothiazol-2-yl) benzenesulfonamides
-
Moreno-Díaz, H.; Villalobos-Molina, R.; Ortiz-Andrade, R.; Díaz-Coutiño, D.; Medina-Franco, J.L.; Webster, S.P; Binnie, M.; Estrada-Soto, S.; Ibarra-Barajas, M.; León-Rivera, I; Navarrete-Vázquez, G. Antidiabetic activity of N-(6-substituted-1, 3-benzothiazol-2-yl)benzenesulfonamides. Bioorg. Med. Chem. Lett, 2008, 18 (9), 2871-2877.
-
(2008)
Bioorg. Med. Chem. Lett
, vol.18
, Issue.9
, pp. 2871-2877
-
-
Moreno-Díaz, H.1
Villalobos-Molina, R.2
Ortiz-Andrade, R.3
Díaz-Coutiño, D.4
Medina-Franco, J.L.5
Webster, S.P.6
Binnie, M.7
Estrada-Soto, S.8
Ibarra-Barajas, M.9
León-Rivera, I.10
Navarrete-Vázquez, G.11
-
138
-
-
67651091643
-
The discovery of azepane sulfonamides as potent 11ß-HSD1 inhibitors
-
Neelamkavil, S.F; Boyle, CD.; Chackalamannil, S.; Greenlee, W.J.; Zhang, L.; Terracina, G. The discovery of azepane sulfonamides as potent 11ß-HSD1 inhibitors. Bioorg. Med. Chem. Lett, 2009, 19 (16), 4563-4565.
-
(2009)
Bioorg. Med. Chem. Lett
, vol.19
, Issue.16
, pp. 4563-4565
-
-
Neelamkavil, S.F.1
Boyle, C.D.2
Chackalamannil, S.3
Greenlee, W.J.4
Zhang, L.5
Terracina, G.6
-
139
-
-
42049102780
-
The Role of 11Beta-Hydroxysteroid Dehydrogenase in Metabolic Disease and Therapeutic Potential of 11Beta-HSD1 Inhibitors
-
Saiah, E. The Role of 11Beta-Hydroxysteroid Dehydrogenase in Metabolic Disease and Therapeutic Potential of 11Beta-HSD1 Inhibitors. Curr. Med. Chem., 2008, 15 (7), 642-649.
-
(2008)
Curr. Med. Chem.
, vol.15
, Issue.7
, pp. 642-649
-
-
Saiah, E.1
-
140
-
-
33846165085
-
Adamantane sulfone and sulfonamide 11-[beta]-HSD1 Inhibitors
-
Sorensen, B.; Winn, M.; Rohde, J.; Shuai, Q.; Wang, J.; Fung, S.; Monzon, K.; Chiou, W.; Stolarik, D.; Imade, H.; Pan, L.; Deng, X.; Chovan, L.; Longenecker, K.; Judge, R.; Qin, W.; Brune, M.; Camp, H.; Frevert, E.U.; Jacobson, P.; Link, J.T Adamantane sulfone and sulfonamide 11-[beta]-HSD1 Inhibitors. Bioorg. Med. Chem. Lett, 2007, 17 (2), 527-532.
-
(2007)
Bioorg. Med. Chem. Lett
, vol.17
, Issue.2
, pp. 527-532
-
-
Sorensen, B.1
Winn, M.2
Rohde, J.3
Shuai, Q.4
Wang, J.5
Fung, S.6
Monzon, K.7
Chiou, W.8
Stolarik, D.9
Imade, H.10
Pan, L.11
Deng, X.12
Chovan, L.13
Longenecker, K.14
Judge, R.15
Qin, W.16
Brune, M.17
Camp, H.18
Frevert, E.U.19
Jacobson, P.20
Link, J.T.21
more..
-
141
-
-
77953284860
-
Modulation of 11[beta]-hydroxysteroid dehydrogenase type 1 activity by 1, 5-substituted 1H-tetrazoles
-
Webster, S.P; Binnie, M.; McConnell, KMM.; Sooy, K.; Ward, P.; Greaney, M.F.; Vinter, A.; Pallin, T.D.; Dyke, H.J.; Gill, M.I.A.; Warner, I; Seckl, J.R.; Walker, B.R. Modulation of 11[beta]-hydroxysteroid dehydrogenase type 1 activity by 1, 5-substituted 1H-tetrazoles. Bioorg. Med. Chem. Lett, 2010, 20 (11), 3265-3271.
-
(2010)
Bioorg. Med. Chem. Lett
, vol.20
, Issue.11
, pp. 3265-3271
-
-
Webster, S.P.1
Binnie, M.2
McConnell, K.M.M.3
Sooy, K.4
Ward, P.5
Greaney, M.F.6
Vinter, A.7
Pallin, T.D.8
Dyke, H.J.9
Gill, M.I.A.10
Warner, I.11
Seckl, J.R.12
Walker, B.R.13
-
142
-
-
34250171175
-
Novel non-steroidal inhibitors of human 11betahydroxysteroid dehydrogenase type 1
-
Vicker, N; Su, X.; Ganeshapillai, D.; Smith, A.; Purohit, A.; Reed, M.J.; Potter, B.V. Novel non-steroidal inhibitors of human 11betahydroxysteroid dehydrogenase type 1. J. Steroid Biochem. Mol. Biol, 2007, 104 (3-5), 123-129.
-
(2007)
J. Steroid Biochem. Mol. Biol
, vol.104
, Issue.3-5
, pp. 123-129
-
-
Vicker, N.1
Su, X.2
Ganeshapillai, D.3
Smith, A.4
Purohit, A.5
Reed, M.J.6
Potter, B.V.7
-
143
-
-
0032897899
-
Protein Tyrosine Phosphatases; Their Role in Insulin Action and Potential as Drug Targets
-
Evans, J.L.; Jallal, B. Protein Tyrosine Phosphatases; Their Role in Insulin Action and Potential as Drug Targets. Exp. Opin. Invest. Drugs 1999, 8 (2), 139-160.
-
(1999)
Exp. Opin. Invest. Drugs
, vol.8
, Issue.2
, pp. 139-160
-
-
Evans, J.L.1
Jallal, B.2
-
144
-
-
0030953448
-
Protein tyrosine phosphatases in signal transduction
-
Neel, B.G.; Tonks, N.K. Protein tyrosine phosphatases in signal transduction. Curr. Opin. Cell Biol, 1997, 9 (2), 193-204.
-
(1997)
Curr. Opin. Cell Biol
, vol.9
, Issue.2
, pp. 193-204
-
-
Neel, B.G.1
Tonks, N.K.2
-
145
-
-
34347260715
-
Recent Development of Small Molecular Specic Inhibitor of ProteinTyrosine Phosphatase 1B
-
Lee, S.; Wang, Q. Recent Development of Small Molecular Specic Inhibitor of ProteinTyrosine Phosphatase 1B. Med. Res. Rev., 2007, 27 (4), 553-573.
-
(2007)
Med. Res. Rev.
, vol.27
, Issue.4
, pp. 553-573
-
-
Lee, S.1
Wang, Q.2
-
146
-
-
0036090978
-
Protein Tyrosine Phosphatase 1B: A New Target for the Treatment of Obesity and Associated Co-Morbidities
-
Ukkola, O.; Santaniemi, M. Protein Tyrosine Phosphatase 1B: A New Target for the Treatment of Obesity and Associated Co-Morbidities. J. Intern. Med, 2002, 252 (6), 467-475.
-
(2002)
J. Intern. Med
, vol.252
, Issue.6
, pp. 467-475
-
-
Ukkola, O.1
Santaniemi, M.2
-
147
-
-
0026500524
-
Protein-Tyrosine Phosphatases and the Regulation of Insulin Action
-
Goldstein, B.J. Protein-Tyrosine Phosphatases and the Regulation of Insulin Action. J. Cell. Biochem., 1992, 48 (1), 33-42.
-
(1992)
J. Cell. Biochem.
, vol.48
, Issue.1
, pp. 33-42
-
-
Goldstein, B.J.1
-
148
-
-
0033525870
-
Increased Insulin Sensitivity and Obesity Resistance in Mice Lacking the Protein-Tyrosine Phosphatase-1B Gene
-
Elchebly, M.; Payette, P.; Michaliszyn, E.; Cromlish, W.; Collins, S.; Loy, A.L.; Normandin, D.; Cheng, A.; Himms-Hagen, J.; Chan, C.C; Ramachandran, C; Gresser, M.J.; Tremblay, M.L.; Kennedy, B.P Increased Insulin Sensitivity and Obesity Resistance in Mice Lacking the Protein-Tyrosine Phosphatase-1B Gene. Science, 1999, 283 (5407), 1544-1548.
-
(1999)
Science
, vol.283
, Issue.5407
, pp. 1544-1548
-
-
Elchebly, M.1
Payette, P.2
Michaliszyn, E.3
Cromlish, W.4
Collins, S.5
Loy, A.L.6
Normandin, D.7
Cheng, A.8
Himms-Hagen, J.9
Chan, C.C.10
Ramachandran, C.11
Gresser, M.J.12
Tremblay, M.L.13
Kennedy, B.P.14
-
149
-
-
0033942614
-
Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice
-
Klaman, L.D.; Boss, O.; Peroni, O.D.; Kim, J.K.; Martino, J.L.; Zabotny, J.M.; Moghal, N; Lubkin, M.; Kim, Y.B.; Sharpe, A.H.; Stricker-Krongrad, A.; Shulman, G.I.; Neel, B.G.; Kahn, B.B. Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice. Mol Cell. Biol, 2000, 20 (15), 5479-5489.
-
(2000)
Mol Cell. Biol
, vol.20
, Issue.15
, pp. 5479-5489
-
-
Klaman, L.D.1
Boss, O.2
Peroni, O.D.3
Kim, J.K.4
Martino, J.L.5
Zabotny, J.M.6
Moghal, N.7
Lubkin, M.8
Kim, Y.B.9
Sharpe, A.H.10
Stricker-Krongrad, A.11
Shulman, G.I.12
Neel, B.G.13
Kahn, B.B.14
-
150
-
-
0036183603
-
Coordinated action of protein tyrosine phosphatases in insulin signal transduction
-
Cheng, A.; Dube, N; Gu, F.; Trembley, M.L. Coordinated action of protein tyrosine phosphatases in insulin signal transduction. Eur. J. Biochem., 2002, 269 (4), 1050-1059.
-
(2002)
Eur. J. Biochem.
, vol.269
, Issue.4
, pp. 1050-1059
-
-
Cheng, A.1
Dube, N.2
Gu, F.3
Trembley, M.L.4
-
151
-
-
0035347144
-
CD45: New jobs for an old acquaintance
-
Penninger, J.M.; Irie-Sasaki, J.; Sasaki, T.; Oliveira-dos-Santos, A. CD45: New jobs for an old acquaintance. J. Nat. Immunol, 2001, 2 (5), 389-396.
-
(2001)
J. Nat. Immunol
, vol.2
, Issue.5
, pp. 389-396
-
-
Penninger, J.M.1
Irie-Sasaki, J.2
Sasaki, T.3
Oliveira-Dos-Santos, A.4
-
152
-
-
0033600797
-
The protein-tyrosine phosphatase TCPTP regulates epidermal growth factor receptor-mediated and phosphatidylinositol 3-kinase-dependent signaling
-
Tiganis, T.; Kemp, B.E.; Tonks, N.K. The protein-tyrosine phosphatase TCPTP regulates epidermal growth factor receptor-mediated and phosphatidylinositol 3-kinase-dependent signaling. J. Biol. Chem., 1999, 274 (39), 27768-27775.
-
(1999)
J. Biol. Chem.
, vol.274
, Issue.39
, pp. 27768-27775
-
-
Tiganis, T.1
Kemp, B.E.2
Tonks, N.K.3
-
153
-
-
0038661384
-
Inhibitors of protein tyrosine phosphatase 1B (PTP1B)
-
Taylor, S.D. Inhibitors of protein tyrosine phosphatase 1B (PTP1B). Curr. Top. Med. Chem., 2003, 3 (7), 759-782.
-
(2003)
Curr. Top. Med. Chem.
, vol.3
, Issue.7
, pp. 759-782
-
-
Taylor, S.D.1
-
154
-
-
3843121119
-
Prospects for inhibitors of protein tyrosine phosphatase 1B as antidiabetic drugs
-
Hooft van Huijsduijnen, R.H.; Sauer, W.H.B.; Bombrun, A.; Swinnen, D. Prospects for inhibitors of protein tyrosine phosphatase 1B as antidiabetic drugs. J. Med. Chem., 2004, 47 (17), 4142-4146.
-
(2004)
J. Med. Chem.
, vol.47
, Issue.17
, pp. 4142-4146
-
-
Hooft Van Huijsduijnen, R.H.1
Sauer, W.H.B.2
Bombrun, A.3
Swinnen, D.4
-
155
-
-
21244444303
-
Inhibitors of protein tyrosine phosphatases: Next-generation drugs
-
Bialy, L.; Waldmann, H. Inhibitors of protein tyrosine phosphatases: Next-generation drugs? Angew. Chem. Int. Ed, 2005, 44 (25), 3814-3839.
-
(2005)
Angew. Chem. Int. Ed
, vol.44
, Issue.25
, pp. 3814-3839
-
-
Bialy, L.1
Waldmann, H.2
-
156
-
-
77949845981
-
Recent Advances in the Discovery of Competitive Protein Tyrosine Phosphatase 1B Inhibitors for the Treatment of Diabetes, Obesity, and Cancer
-
Combs, A. P. Recent Advances in the Discovery of Competitive Protein Tyrosine Phosphatase 1B Inhibitors for the Treatment of Diabetes, Obesity, and Cancer. J. Med. Chem., 2010, 53 (6), 2333-2344.
-
(2010)
J. Med. Chem.
, vol.53
, Issue.6
, pp. 2333-2344
-
-
Combs, A.P.1
-
157
-
-
0041809012
-
Protein Tyrosine Phosphatase 1B Inhibition: Opportunities and Challenges
-
Liu, G. Protein Tyrosine Phosphatase 1B Inhibition: Opportunities and Challenges. Curr. Med. Chem., 2003, 10 (15), 1407-1421.
-
(2003)
Curr. Med. Chem.
, vol.10
, Issue.15
, pp. 1407-1421
-
-
Liu, G.1
-
158
-
-
0028077830
-
Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp
-
Burke, T.R., Jr.; Kole, H.K.; Roller, P.P. Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp. Biochem. Biophys. Res. Commun., 1994, 204 (1), 129-134.
-
(1994)
Biochem. Biophys. Res. Commun.
, vol.204
, Issue.1
, pp. 129-134
-
-
Burke, Jr.T.R.1
Kole, H.K.2
Roller, P.P.3
-
159
-
-
0043022181
-
Acylsulfonamide-containing PTP1B inhibitors designed to mimic an enzyme-bound water of hydration
-
Liu, D.-G.; Gao, Y; Voigt, J.H.; Lee, K.; Nicklaus, M.C.; Wu, L.; Zhang, Z.-Y; Burke, T.R. Acylsulfonamide-containing PTP1B inhibitors designed to mimic an enzyme-bound water of hydration. Bioorg. Med. Chem. Lett, 2003, 13 (18), 3005-3007.
-
(2003)
Bioorg. Med. Chem. Lett
, vol.13
, Issue.18
, pp. 3005-3007
-
-
Liu, D.-G.1
Gao, Y.2
Voigt, J.H.3
Lee, K.4
Nicklaus, M.C.5
Wu, L.6
Zhang, Z.-Y.7
Burke, T.R.8
-
160
-
-
23944466408
-
Discovery and structure-activity relationships of novel sulfonamides as potent PTP1B inhibitors
-
Holmes, CP.; Li, X.; Pan, Y; Xu, C; Bhandari, A.; Moody, CM.; Miguel, J.A.; Ferla, S.W.; De Francisco, M.N.; Frederick, B.T.; Zhou, S.; Macher, N.; Jang, L.; Irvine, J.D.; Grove, J.R. Discovery and structure-activity relationships of novel sulfonamides as potent PTP1B inhibitors. Bioorg. Med. Chem. Lett, 2005, 15 (19), 4336-4341.
-
(2005)
Bioorg. Med. Chem. Lett
, vol.15
, Issue.19
, pp. 4336-4341
-
-
Holmes, C.P.1
Li, X.2
Pan, Y.3
Xu, C.4
Bhandari, A.5
Moody, C.M.6
Miguel, J.A.7
Ferla, S.W.8
De Francisco, M.N.9
Frederick, B.T.10
Zhou, S.11
MacHer, N.12
Jang, L.13
Irvine, J.D.14
Grove, J.R.15
-
161
-
-
1842424803
-
Protein tyrosine phosphatase-1B dephosphorylation of the insulin receptor occurs in a perinuclear endosome compartment in human embryonic kidney 293 cells
-
Romsicki, Y; Reece, M.; Gauthier, J.-Y; Asante-Appiah, E.; Kennedy, B.P. Protein tyrosine phosphatase-1B dephosphorylation of the insulin receptor occurs in a perinuclear endosome compartment in human embryonic kidney 293 cells. J. Biol. Chem., 2004, 279 (13), 12868-12875.
-
(2004)
J. Biol. Chem.
, vol.279
, Issue.13
, pp. 12868-12875
-
-
Romsicki, Y.1
Reece, M.2
Gauthier, J.-Y.3
Asante-Appiah, E.4
Kennedy, B.P.5
-
162
-
-
47349122949
-
A re-examination of the difluoromethylenesulfonic acid group as a phosphotyrosine mimic for PTP1B inhibition
-
Hussain, M.; Ahmed, V; Hill, B.; Ahmed, Z.; Taylor, S.D. A re-examination of the difluoromethylenesulfonic acid group as a phosphotyrosine mimic for PTP1B inhibition. Bioorg. Med. Chem., 2008, 16 (14), 6764-6777.
-
(2008)
Bioorg. Med. Chem.
, vol.16
, Issue.14
, pp. 6764-6777
-
-
Hussain, M.1
Ahmed, V.2
Hill, B.3
Ahmed, Z.4
Taylor, S.D.5
-
163
-
-
0037377337
-
Structure-based design and discovery of novel inhibitors of protein tyrosine phosphatases
-
Huang, P.; Ramphal, J.; Wei, J.; Liang, C; Jallal, B.; McMahon, G.; Tang, C. Structure-based design and discovery of novel inhibitors of protein tyrosine phosphatases. Bioorg. Med. Chem., 2003, 11, 1835-1849.
-
(2003)
Bioorg. Med. Chem.
, vol.11
, pp. 1835-1849
-
-
Huang, P.1
Ramphal, J.2
Wei, J.3
Liang, C.4
Jallal, B.5
McMahon, G.6
Tang, C.7
-
164
-
-
0035846571
-
Steric hindrance as a basis for structure-based design of selective inhibitors of protein-tyrosine phosphatases
-
Iversen, L.F.; Andersen, H.S.; Møller, K.B.; Olsen, O.H.; Peters, G.H.; Branner, S.; Mortensen, S.B.; Hansen, T.K.; Lau, J.; Ge, Y; Holsworth, D.D.; Newman, M.J.; Hundahl Møller, N.P Steric hindrance as a basis for structure-based design of selective inhibitors of protein-tyrosine phosphatases. Biochemistry, 2001, 40 (49), 14812-14820.
-
(2001)
Biochemistry
, vol.40
, Issue.49
, pp. 14812-14820
-
-
Iversen, L.F.1
Andersen, H.S.2
Møller, K.B.3
Olsen, O.H.4
Peters, G.H.5
Branner, S.6
Mortensen, S.B.7
Hansen, T.K.8
Lau, J.9
Ge, Y.10
Holsworth, D.D.11
Newman, M.J.12
Hundahl Møller, N.P.13
-
165
-
-
0038248863
-
Discovery and Structure-Activity Relationship of Oxalylarylaminobenzoic Acids as Inhibitors of Protein Tyrosine Phosphatase 1B
-
Liu, G.; Szczepankiewicz, B.G.; Pei, Z.; Janowick, D.A.; Xin, Z.; Hajduk, P.J.; Abad-Zapatero, C; Liang, H.; Hutchins, C.W.; Fesik, S.W.; Ballaron, S.J.; Stashko, M.A.; Lubben, T.; Mika, A.K.; Zinker, B.A.; Trevillyan, J.M.; Jirousek, M.R. Discovery and Structure-Activity Relationship of Oxalylarylaminobenzoic Acids as Inhibitors of Protein Tyrosine Phosphatase 1B. J. Med. Chem., 2003, 46 (11), 2093-2103.
-
(2003)
J. Med. Chem.
, vol.46
, Issue.11
, pp. 2093-2103
-
-
Liu, G.1
Szczepankiewicz, B.G.2
Pei, Z.3
Janowick, D.A.4
Xin, Z.5
Hajduk, P.J.6
Abad-Zapatero, C.7
Liang, H.8
Hutchins, C.W.9
Fesik, S.W.10
Ballaron, S.J.11
Stashko, M.A.12
Lubben, T.13
Mika, A.K.14
Zinker, B.A.15
Trevillyan, J.M.16
Jirousek, M.R.17
-
166
-
-
34648833338
-
Structure-Based Optimization of Protein Tyrosine Phosphatase 1B Inhibitors: From the Active Site to the Second Phosphotyrosine Binding Site
-
Wilson, D.P; Wan, Z.-K.; Xu, W.-X.; Kirincich, S.J.; Follows, B.C.; Joseph-McCarthy, D.; Foreman, K.; Moretto, A.; Wu, J.; Zhu, M.; Binnun, E.; Zhang, Y.-L.; Tam, M.; Erbe, D.V; Tobin, J.; Xu, X.; Leung, L.; Shilling, A.; Tam, S.Y; Mansour, T.S.; Lee, J. Structure-Based Optimization of Protein Tyrosine Phosphatase 1B Inhibitors: From the Active Site to the Second Phosphotyrosine Binding Site. J. Med. Chem., 2007, 50 (19), 4681-4698.
-
(2007)
J. Med. Chem.
, vol.50
, Issue.19
, pp. 4681-4698
-
-
Wilson, D.P.1
Wan, Z.-K.2
Xu, W.-X.3
Kirincich, S.J.4
Follows, B.C.5
Joseph-Mccarthy, D.6
Foreman, K.7
Moretto, A.8
Wu, J.9
Zhu, M.10
Binnun, E.11
Zhang, Y.-L.12
Tam, M.13
Erbe, D.V.14
Tobin, J.15
Xu, X.16
Leung, L.17
Shilling, A.18
Tam, S.Y.19
Mansour, T.S.20
Lee, J.21
more..
-
167
-
-
84863733743
-
-
WO2003082841
-
Coppola, GM.; Davies, J.W.; Jewell, CF., Jr.; Li, Y.-C; Wareing, J.R.; Sperbeck, D.M.; Stams, T.M.; Topiol, S.W.; Vlattas, I. Preparation of Substituted 1, 1-Dioxo-1, 2, 5-thiazolidine-3-ones as Protein Tyrosine Phosphatase 1b and T-Cell Protein Tyrosine Phosphatase Inhibitors to Mitigate Insulin Resistance in the Treatment of Diabetes or Atherosclerosis. WO2003082841, 2003.
-
(2003)
Vlattas, I. Preparation of Substituted 1, 1-Dioxo-1, 2, 5-thiazolidine-3-ones As Protein Tyrosine Phosphatase 1b and T-Cell Protein Tyrosine Phosphatase Inhibitors to Mitigate Insulin Resistance in the Treatment of Diabetes or Atherosclerosis
-
-
Coppola, G.M.1
Davies, J.W.2
Jewell, Jr.C.F.3
Li, Y.-C.4
Wareing, J.R.5
Sperbeck, D.M.6
Stams, T.M.7
Topiol, S.W.8
-
168
-
-
84863733744
-
-
WO2004041799
-
Birch, A.M.; Kenny, P.W.; Morley, A.D.; Russell, D.J.; Toader, D. Preparation of 5-(Substituted phenyl)thiadiazolidin-3-ones as Inhibitors of Protein Tyrosine Phosphatase 1B. WO2004041799, 2004.
-
(2004)
Preparation of 5-(Substituted phenyl)thiadiazolidin-3-ones As Inhibitors of Protein Tyrosine Phosphatase 1B
-
-
Birch, A.M.1
Kenny, P.W.2
Morley, A.D.3
Russell, D.J.4
Toader, D.5
-
170
-
-
84863762016
-
-
WO2005035551
-
Combs, A.P.; Yue, E.W.T.; Bower, M.J.; Zhu, W.; Crawley, M.L.; Sparks, R.B.; Pruitt, J.R.; Takvorian, A. Inhibitors of Proteins That Bind Phosphorylated Molecules. WO2005035551, 2005.
-
(2005)
Inhibitors of Proteins That Bind Phosphorylated Molecules
-
-
Combs, A.P.1
Yue, E.W.T.2
Bower, M.J.3
Zhu, W.4
Crawley, M.L.5
Sparks, R.B.6
Pruitt, J.R.7
Takvorian, A.8
-
171
-
-
27144444772
-
Structure-Based Design and Discovery of Protein Tyrosine Phosphatase Inhibitors Incorporating Novel Isothiazolidinone Heterocyclic Phosphotyrosine Mimetics
-
Combs, A.P.; Yue, E.W.; Bower, M.; Ala, P.J.; Wayland, B.; Douty, B.; Takvorian, A.; Polam, P.; Wasserman, Z.; Zhu, W.; Crawley, M.L.; Pruitt, J.; Sparks, R.; Glass, B.; Modi, D.; McLaughlin, E.; Bostrom, L.; Li, M.; Galya, L.; Blom, K.; Hillman, M.; Gonneville, L.; Reid, B.G.; Wei, M.; Becker-Pasha, M.; Klabe, R.; Huber, R.; Li, Y.; Hollis, G.; Burn, T.C.; Wynn, R.; Liu, P.; Metcalf, B. Structure-Based Design and Discovery of Protein Tyrosine Phosphatase Inhibitors Incorporating Novel Isothiazolidinone Heterocyclic Phosphotyrosine Mimetics. J. Med. Chem., 2005, 48 (21), 6544-6548.
-
(2005)
J. Med. Chem.
, vol.48
, Issue.21
, pp. 6544-6548
-
-
Combs, A.P.1
Yue, E.W.2
Bower, M.3
Ala, P.J.4
Wayland, B.5
Douty, B.6
Takvorian, A.7
Polam, P.8
Wasserman, Z.9
Zhu, W.10
Crawley, M.L.11
Pruitt, J.12
Sparks, R.13
Glass, B.14
Modi, D.15
McLaughlin, E.16
Bostrom, L.17
Li, M.18
Galya, L.19
Blom, K.20
Hillman, M.21
Gonneville, L.22
Reid, B.G.23
Wei, M.24
Becker-Pasha, M.25
Klabe, R.26
Huber, R.27
Li, Y.28
Hollis, G.29
Burn, T.C.30
Wynn, R.31
Liu, P.32
Metcalf, B.33
more..
-
172
-
-
33746036019
-
Isothiazolidinone heterocycles as inhibitors of protein tyrosine phosphatases: Synthesis and structure-activity relationships of a peptide scaffold
-
Yue, E.W.; Wayland, B.; Douty, B.; Crawley, M.L.; McLaughlin, E.; Takvorian, A.; Wasserman, Z.; Bower, M.J.; Wei, M.; Li, Y.; Ala, P.J.; Gonneville, L.; Wynn, R.; Burn, T.C.; Liu, P.C.C.; Combs, A.P. Isothiazolidinone heterocycles as inhibitors of protein tyrosine phosphatases: Synthesis and structure-activity relationships of a peptide scaffold. Bioorg. Med. Chem., 2006, 14 (17), 5833-5849.
-
(2006)
Bioorg. Med. Chem.
, vol.14
, Issue.17
, pp. 5833-5849
-
-
Yue, E.W.1
Wayland, B.2
Douty, B.3
Crawley, M.L.4
McLaughlin, E.5
Takvorian, A.6
Wasserman, Z.7
Bower, M.J.8
Wei, M.9
Li, Y.10
Ala, P.J.11
Gonneville, L.12
Wynn, R.13
Burn, T.C.14
Liu, P.C.C.15
Combs, A.P.16
-
173
-
-
33745658606
-
Potent Benzimidazole Sulfonamide Protein Tyrosine Phosphatase 1B Inhibitors Containing the Heterocyclic (S)-Isothiazolidinone Phosphotyrosine Mimetic
-
Combs, A.P.; Zhu, W.; Crawley, M.L.; Glass, B.; Polam, P.; Sparks, R.B.; Modi, D.; Takvorian, A.; McLaughlin, E.; Yue, E.W.; Wasserman, Z.; Bower, M.; Wei, M.; Rupar, M.; Ala, P.J.; Reid, B.M.; Ellis, D.; Gonneville, L.; Emm, T.; Taylor, N.; Yeleswaram, S.; Li, Y.; Wynn, R.; Burn, T.C.; Hollis, G.; Liu, P.C.C.; Metcalf, B. Potent Benzimidazole Sulfonamide Protein Tyrosine Phosphatase 1B Inhibitors Containing the Heterocyclic (S)-Isothiazolidinone Phosphotyrosine Mimetic. J. Med. Chem., 2006, 49 (13), 3774-3789.
-
(2006)
J. Med. Chem.
, vol.49
, Issue.13
, pp. 3774-3789
-
-
Combs, A.P.1
Zhu, W.2
Crawley, M.L.3
Glass, B.4
Polam, P.5
Sparks, R.B.6
Modi, D.7
Takvorian, A.8
McLaughlin, E.9
Yue, E.W.10
Wasserman, Z.11
Bower, M.12
Wei, M.13
Rupar, M.14
Ala, P.J.15
Reid, B.M.16
Ellis, D.17
Gonneville, L.18
Emm, T.19
Taylor, N.20
Yeleswaram, S.21
Li, Y.22
Wynn, R.23
Burn, T.C.24
Hollis, G.25
Liu, P.C.C.26
Metcalf, B.27
more..
-
174
-
-
33846397105
-
Benzothiazole benzimidazole (S)-isothiazolidinone derivatives as protein tyrosine phosphatase-1B inhibitors
-
Sparks, R.B.; Polam, P.; Zhu, W.; Crawley, M.L.; Takvorian, A.; McLaughlin, E.; Wei, M.; Ala, P.J.; Gonneville, L.; Taylor, N.; Li, Y.; Wynn, R.; Burn, T.C.; Liu, P.C.C.; Combs, A.P. Benzothiazole benzimidazole (S)-isothiazolidinone derivatives as protein tyrosine phosphatase-1B inhibitors. Bioorg. Med. Chem. Lett., 2007, 17 (3), 736-740.
-
(2007)
Bioorg. Med. Chem. Lett.
, vol.17
, Issue.3
, pp. 736-740
-
-
Sparks, R.B.1
Polam, P.2
Zhu, W.3
Crawley, M.L.4
Takvorian, A.5
McLaughlin, E.6
Wei, M.7
Ala, P.J.8
Gonneville, L.9
Taylor, N.10
Li, Y.11
Wynn, R.12
Burn, T.C.13
Liu, P.C.C.14
Combs, A.P.15
-
175
-
-
37549060353
-
Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolines
-
Douty, B.; Wayland, B.; Ala, P.J.; Bower, M.J.; Pruitt, J.; Bostrom, L.; Wei, M.; Klabe, R.; Gonneville, L.; Wynn, R.; Burn, T.C.; Liu, P.C.C.; Combs, A.P.; Yue, E.W. Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolines. Bioorg. Med. Chem. Lett., 2008, 18 (1), 66-71.
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, Issue.1
, pp. 66-71
-
-
Douty, B.1
Wayland, B.2
Ala, P.J.3
Bower, M.J.4
Pruitt, J.5
Bostrom, L.6
Wei, M.7
Klabe, R.8
Gonneville, L.9
Wynn, R.10
Burn, T.C.11
Liu, P.C.C.12
Combs, A.P.13
Yue, E.W.14
-
176
-
-
65249135612
-
Synthesis vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity
-
Navarrete-Vazquez, G.; Paoli, P.; León-Rivera, I.; Villalobos-Molina, R.; Medina-Franco, J.L.; Ortiz-Andrade, R.; Estrada-Soto, S.; Camici, G.; Diaz-Coutiño, D.; Gallardo-Ortiz, I.; Martinez-Mayorga, K.; Moreno-Díaz, H. Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2- arylsulfonylaminobenzothiazoles with antihyperglycemic activity. Bioorg. Med. Chem., 2009, 17 (9), 3332-3341.
-
(2009)
Bioorg. Med. Chem.
, vol.17
, Issue.9
, pp. 3332-3341
-
-
Navarrete-Vazquez, G.1
Paoli, P.2
León-Rivera, I.3
Villalobos-Molina, R.4
Medina-Franco, J.L.5
Ortiz-Andrade, R.6
Estrada-Soto, S.7
Camici, G.8
Diaz-Coutiño, D.9
Gallardo-Ortiz, I.10
Martinez-Mayorga, K.11
Moreno-Díaz, H.12
-
177
-
-
0035847677
-
Sulfonylated aminothiazoles as new small molecule inhibitors of protein phosphatases
-
Wipf, P.; Aslan, D.C.; Southwick, E.C.; Lazo, J.S. Sulfonylated aminothiazoles as new small molecule inhibitors of protein phosphatases. Bioorg. Med. Chem. Lett., 2001, 11 (3), 313-317.
-
(2001)
Bioorg. Med. Chem. Lett.
, vol.11
, Issue.3
, pp. 313-317
-
-
Wipf, P.1
Aslan, D.C.2
Southwick, E.C.3
Lazo, J.S.4
-
179
-
-
70349386312
-
Dipeptidyl Peptidase-4 (CD26): Knowing the Function before Inhibiting the Enzyme
-
Matteucci, E.; Giampietro, O. Dipeptidyl Peptidase-4 (CD26): Knowing the Function before Inhibiting the Enzyme. Curr. Med. Chem., 2009, 16 (23), 2943-2951.
-
(2009)
Curr. Med. Chem.
, vol.16
, Issue.23
, pp. 2943-2951
-
-
Matteucci, E.1
Giampietro, O.2
-
180
-
-
61349143225
-
Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes
-
Havale, S.H.; Pal, M. Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes. Bioorg. Med. Chem., 2009, 17 (5), 1783-1802.
-
(2009)
Bioorg. Med. Chem.
, vol.17
, Issue.5
, pp. 1783-1802
-
-
Havale, S.H.1
Pal, M.2
-
181
-
-
0027215348
-
Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum
-
Mentlein, R.; Gallwitz, B.; Schmidt, W.E. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur. J. Biochem., 1993, 214 (3), 829-835.
-
(1993)
Eur. J. Biochem.
, vol.214
, Issue.3
, pp. 829-835
-
-
Mentlein, R.1
Gallwitz, B.2
Schmidt, W.E.3
-
182
-
-
3843072211
-
Dipeptidyl Peptidase IV Inhibitors for the Treatment of Diabetes
-
Weber, A.E. Dipeptidyl Peptidase IV Inhibitors for the Treatment of Diabetes. J. Med. Chem., 2004, 47 (17), 4135-4141.
-
(2004)
J. Med. Chem.
, vol.47
, Issue.17
, pp. 4135-4141
-
-
Weber, A.E.1
-
183
-
-
2342513750
-
Combined genetic disruption of dual incretin receptor signaling pathways reveals novel glucose lowering properties of DPP-IV inhibitors in mice
-
Hansotia, T.; Baggio, L.; Yamada, Y.; Tsukiyama, K.; Preitner, F.; Thorens, B.; Seino, Y.; Drucker, D. Combined genetic disruption of dual incretin receptor signaling pathways reveals novel glucose lowering properties of DPP-IV inhibitors in mice. Diabetes, 2003, 52 (S1), A77-A78.
-
(2003)
Diabetes
, vol.52
, Issue.S1
-
-
Hansotia, T.1
Baggio, L.2
Yamada, Y.3
Tsukiyama, K.4
Preitner, F.5
Thorens, B.6
Seino, Y.7
Drucker, D.8
-
184
-
-
0037928769
-
The role of dipeptidyl peptidase IV in the cleavage of glucagon family peptides
-
Fenyk-Melody, J.E.; Schmidt, K.; Bagchi, A.; Griffin, P.R.; Thornberry, N.A.; Sinha Roy, R. The role of dipeptidyl peptidase IV in the cleavage of glucagon family peptides. J. Biol. Chem., 2003, 278 (25), 22418-22423.
-
(2003)
J. Biol. Chem.
, vol.278
, Issue.25
, pp. 22418-22423
-
-
Fenyk-Melody, J.E.1
Schmidt, K.2
Bagchi, A.3
Griffin, P.R.4
Thornberry, N.A.5
Sinha Roy, R.6
-
185
-
-
19944427998
-
(2R)-4-oxo-4-[3-(trifluoromethyl)-5, 6-dihydro[1, 2, 4]triazolo[4, 3-A]pyrazin-7(8H)-yl]-1-(2, 4, 5-trifluorophenyl)butan-2-amine: A potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
-
Kim, D.; Wang, L.; Beconi, M.; Eiermann, G.J.; Fischer, M.H.; Huaibing, H.; Hickey, G.J.; Kowalchick, J.E.; Leiting, B.; Lyons, K.; Marsilio, F.; McCann, M.E.; Patel, R.A.; Petrov, A.; Scapin, G.; Patel, S.B.; Sinha Roy, R.; Wu, J.K.; Wyvratt, M.J.; Zhang, B.; Zhu, L.; Thornberry, N.A.; Weber, A.E. (2R)-4-oxo-4-[3-(trifluoromethyl)-5, 6-dihydro[1, 2, 4]triazolo[4, 3-a]pyrazin-7(8H)-yl]-1-(2, 4, 5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. J. Med. Chem., 2005, 48 (1), 141-151.
-
(2005)
J. Med. Chem.
, vol.48
, Issue.1
, pp. 141-151
-
-
Kim, D.1
Wang, L.2
Beconi, M.3
Eiermann, G.J.4
Fischer, M.H.5
Huaibing, H.6
Hickey, G.J.7
Kowalchick, J.E.8
Leiting, B.9
Lyons, K.10
Marsilio, F.11
McCann, M.E.12
Patel, R.A.13
Petrov, A.14
Scapin, G.15
Patel, S.B.16
Sinha Roy, R.17
Wu, J.K.18
Wyvratt, M.J.19
Zhang, B.20
Zhu, L.21
Thornberry, N.A.22
Weber, A.E.23
more..
-
186
-
-
34248999413
-
Discovery of alogliptin: A potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase i v
-
Feng, J.; Zhang, Z.; Wallace, M.B.; Stafford, J.A.; Kaldor, S.W.; Kassel, D.B.; Navre, M.; Shi, L.; Skene, R.J.; Asakawa, T.; Takeuchi, K.; Xu, R.; Webb, D.R.; Gwaltney, S.L. Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase I V. J. Med. Chem., 2007, 50 (10), 2297-2300.
-
(2007)
J. Med. Chem.
, vol.50
, Issue.10
, pp. 2297-2300
-
-
Feng, J.1
Zhang, Z.2
Wallace, M.B.3
Stafford, J.A.4
Kaldor, S.W.5
Kassel, D.B.6
Navre, M.7
Shi, L.8
Skene, R.J.9
Asakawa, T.10
Takeuchi, K.11
Xu, R.12
Webb, D.R.13
Gwaltney, S.L.14
-
187
-
-
0037777695
-
1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: A potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties
-
Villhauer, E.B.; Brinkman, J.A.; Naderi, G.B.; Burkey, B.F.; Dunning, B.E.; Prasad, K.; Mangold, B.L.; Russell, M.E.; Hughes, T.E. 1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties. J. Med. Chem., 2003, 46 (13), 2774-2789.
-
(2003)
J. Med. Chem.
, vol.46
, Issue.13
, pp. 2774-2789
-
-
Villhauer, E.B.1
Brinkman, J.A.2
Naderi, G.B.3
Burkey, B.F.4
Dunning, B.E.5
Prasad, K.6
Mangold, B.L.7
Russell, M.E.8
Hughes, T.E.9
-
188
-
-
22744449063
-
Discovery and preclinical profile of Saxagliptin (BMS-477118): A highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
-
Augeri, D.J.; Robl, J.A.; Betebenner, D.A.; Magnin, D.R.; Khanna, A.; Robertson, J.G.; Wang, A.; Simpkins, L.M.; Taunk, P.; Huang, Q.; Han, S.-P.; Abboa-Offei, B.; Cap, M.; Xin, L.; Tao, L.; Tozzo, E.; Welzel, G.E.; Egan, D.M.; Marc ink eviciene, J.; Chang, S.Y.; Biller, S.A.; Kirby, M.S.; Parker, R.A.; Hamann, L.G. Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. J. Med. Chem., 2005, 48 (15), 5025-5037.
-
(2005)
J. Med. Chem.
, vol.48
, Issue.15
, pp. 5025-5037
-
-
Augeri, D.J.1
Robl, J.A.2
Betebenner, D.A.3
Magnin, D.R.4
Khanna, A.5
Robertson, J.G.6
Wang, A.7
Simpkins, L.M.8
Taunk, P.9
Huang, Q.10
Han, S.-P.11
Abboa-Offei, B.12
Cap, M.13
Xin, L.14
Tao, L.15
Tozzo, E.16
Welzel, G.E.17
Egan, D.M.18
Marc Ink Eviciene, J.19
Chang, S.Y.20
Biller, S.A.21
Kirby, M.S.22
Parker, R.A.23
Hamann, L.G.24
more..
-
189
-
-
0346252638
-
4-Amino cyclohexylglycine analogues as potent dipeptidyl peptidase IV inhibitors
-
Parmee, E.R.; He, J.; Mastracchio, A.; Edmondson, S.D.; Colwell, L.; Eiermann, G.; Feeney, W.P; Habulihaz, B.; He, H.; Kilburn, R.; Leiting, B.; Lyons, K.; Marsilio, F.; Patel, R.A.; Petrov, A.; Di Salvo, J.; Wu, J.K.; Thornberry, N.A.; Weber, A.E. 4-Amino cyclohexylglycine analogues as potent dipeptidyl peptidase IV inhibitors. Bioorg. Med. Chem. Lett, 2004, 14 (1), 43-46.
-
(2004)
Bioorg. Med. Chem. Lett
, vol.14
, Issue.1
, pp. 43-46
-
-
Parmee, E.R.1
He, J.2
Mastracchio, A.3
Edmondson, S.D.4
Colwell, L.5
Eiermann, G.6
Feeney, W.P.7
Habulihaz, B.8
He, H.9
Kilburn, R.10
Leiting, B.11
Lyons, K.12
Marsilio, F.13
Patel, R.A.14
Petrov, A.15
Di Salvo, J.16
Wu, J.K.17
Thornberry, N.A.18
Weber, A.E.19
-
190
-
-
10744220490
-
Diastereoselective synthesis and configuration-dep end ent activity of (3-substituted-cycloalkyl)glycine pyrrolidides and thiazolidides as dipeptidyl peptidase IV inhibitors
-
Ashton, W.T.; Dong, H.; Sisco, RM.; Doss, G.A.; Leiting, B.; Patel, R.A.; Wu, J.K.; Marsilio, F.; Thornberry, N.A.; Weber, A.E. Diastereoselective synthesis and configuration-dep end ent activity of (3-substituted-cycloalkyl) glycine pyrrolidides and thiazolidides as dipeptidyl peptidase IV inhibitors. Bioorg. Med. Chem. Lett., 2004, 14 (4), 859-863.
-
(2004)
Bioorg. Med. Chem. Lett.
, vol.14
, Issue.4
, pp. 859-863
-
-
Ashton, W.T.1
Dong, H.2
Sisco, R.M.3
Doss, G.A.4
Leiting, B.5
Patel, R.A.6
Wu, J.K.7
Marsilio, F.8
Thornberry, N.A.9
Weber, A.E.10
-
191
-
-
58449107784
-
D-420720, A novel orally active sulfonamide compound dipeptidyl peptidase IV inhibitor: Structure and activity relationship of arylsulfonamide to dipeptidyl peptidase IV inhibition
-
Tsai, H.J.; Chou, S.-Y.; Chuang, S.-H.; Chen, C.-C; Hsu, F.-L. D-420720, A novel orally active sulfonamide compound dipeptidyl peptidase IV inhibitor: structure and activity relationship of arylsulfonamide to dipeptidyl peptidase IV inhibition. Drug Dev. Res., 2008, 69 (8), 514-519.
-
(2008)
Drug Dev. Res.
, vol.69
, Issue.8
, pp. 514-519
-
-
Tsai, H.J.1
Chou, S.-Y.2
Chuang, S.-H.3
Chen, C.-C.4
Hsu, F.-L.5
-
192
-
-
23644440644
-
Diprolyl nitriles as potent dipeptidyl peptidase IV inhibitors
-
Zhao, G.; Taunk, P.C.; Magnin, D.R.; Simpkins, L.M.; Robl, J.A.; Wang, A.; Robertson, J.G.; Marc inkeviciene, J.; Sitkoff, D.F.; Parker, R.A.; Kirby, M.S.; Hamann, L.G. Diprolyl nitriles as potent dipeptidyl peptidase IV inhibitors. Bioorg. Med. Chem. Lett., 2005, 15 (18), 3992-3995.
-
(2005)
Bioorg. Med. Chem. Lett.
, vol.15
, Issue.18
, pp. 3992-3995
-
-
Zhao, G.1
Taunk, P.C.2
Magnin, D.R.3
Simpkins, L.M.4
Robl, J.A.5
Wang, A.6
Robertson, J.G.7
Marc Inkeviciene, J.8
Sitkoff, D.F.9
Parker, R.A.10
Kirby, M.S.11
Hamann, L.G.12
-
193
-
-
34247204289
-
Discovery and Structure-Activity Relationships of Piperidinone-and Piperidine-Constrained Phenethylamines as Novel, Potent, and Selective Dipeptidyl Peptidase IV Inhibitors
-
Pei, Z.; Li, X.; von Geldern, TW.; Longenecker, K.; Pireh, D.; Stewart, K.D.; Backes, B.J.; Lai, C; Lubben, T.H.; Ballaron, S.J.; Beno, D.W.A.; Kempf-Grote, A.J.; Sham, H.L.; Trevillyan, JM. Discovery and Structure-Activity Relationships of Piperidinone-and Piperidine-Constrained Phenethylamines as Novel, Potent, and Selective Dipeptidyl Peptidase IV Inhibitors. J. Med. Chem., 2007, 50 (8), 1983-1987.
-
(2007)
J. Med. Chem.
, vol.50
, Issue.8
, pp. 1983-1987
-
-
Pei, Z.1
Li, X.2
Von Geldern, T.W.3
Longenecker, K.4
Pireh, D.5
Stewart, K.D.6
Backes, B.J.7
Lai, C.8
Lubben, T.H.9
Ballaron, S.J.10
Beno, D.W.A.11
Kempf-Grote, A.J.12
Sham, H.L.13
Trevillyan, J.M.14
-
194
-
-
33847628449
-
Pyrrolidine-constrained phenethylamines: The design of potent, selective, and pharmacologically efficacious dipeptidyl peptidase IV (DPP4) inhibitors from a lead-like screening hit
-
Backes, B.J.; Longenecker, K.; Hamilton, G.L.; Stewart, K.; Lai, C.; Kopecka, H.; von Geldern, T.W.; Madar, D.J.; Pei, Z.; Lubben, TH.; Zinker, B.A.; Tian, Z.; Ballaron, S.J.; Stashko, M.A.; Mika, A.K.; Beno, D.W.A.; Kempf-Grote, A.J.; Black-Schaefer, C.; Sham, H.L.; Trevillyan, JM. Pyrrolidine-constrained phenethylamines: The design of potent, selective, and pharmacologically efficacious dipeptidyl peptidase IV (DPP4) inhibitors from a lead-like screening hit. Bioorg. Med. Chem. Lett, 2007, 17 (7), 2005-2012.
-
(2007)
Bioorg. Med. Chem. Lett
, vol.17
, Issue.7
, pp. 2005-2012
-
-
Backes, B.J.1
Longenecker, K.2
Hamilton, G.L.3
Stewart, K.4
Lai, C.5
Kopecka, H.6
Von Geldern, T.W.7
Madar, D.J.8
Pei, Z.9
Lubben, T.H.10
Zinker, B.A.11
Tian, Z.12
Ballaron, S.J.13
Stashko, M.A.14
Mika, A.K.15
Beno, D.W.A.16
Kempf-Grote, A.J.17
Black-Schaefer, C.18
Sham, H.L.19
Trevillyan, J.M.20
more..
-
195
-
-
53349165532
-
(3R)-3-Amino-4-(2, 4, 5-trifluorophenyl)-N-{4-[6-(2-methoxyethoxy) benzothiazol-2-yl]tetrahydropyran-4-yl}butanamide as a potent dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
-
Nitta, A.; Fujii, H.; Sakami, S.; Nishimura, Y.; Ohyama, T; Satoh, M.; Nakaki, J.; Satoh, S.; Inada, C; Kozono, H.; Kumagai, H.; Shimamura, M.; Fukazawa, T.; Kawai, H. (3R)-3-Amino-4-(2, 4, 5-trifluorophenyl)-N-{4-[6-(2- methoxyethoxy)benzothiazol-2-yl]tetrahydropyran-4-yl}butanamide as a potent dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Bioorg. Med. Chem. Lett, 2008, 18 (20), 5435-5438.
-
(2008)
Bioorg. Med. Chem. Lett
, vol.18
, Issue.20
, pp. 5435-5438
-
-
Nitta, A.1
Fujii, H.2
Sakami, S.3
Nishimura, Y.4
Ohyama, T.5
Satoh, M.6
Nakaki, J.7
Satoh, S.8
Inada, C.9
Kozono, H.10
Kumagai, H.11
Shimamura, M.12
Fukazawa, T.13
Kawai, H.14
-
196
-
-
56249143071
-
Synthesis and biological evaluation of homopiperazine derivatives with [beta]-aminoacyl group as dipeptidyl peptidase IV inhibitors
-
Ahn, J.H.; Park, W.S.; Jun, M.A.; Shin, M.S.; Kang, S.K.; Kim, K. Y; Rhee, S.D.; Bae, M.A.; Kim, K.R.; Kim, S.G.; Kim, S.Y; Sohn, S.K.; Kang, N.S.; Lee, J.O.; Lee, D.H.; Cheon, H.G.; Kim, S.S. Synthesis and biological evaluation of homopiperazine derivatives with [beta]-aminoacyl group as dipeptidyl peptidase IV inhibitors. Bioorg. Med. Chem. Lett., 2008, 18 (24), 6525-6529.
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, Issue.24
, pp. 6525-6529
-
-
Ahn, J.H.1
Park, W.S.2
Jun, M.A.3
Shin, M.S.4
Kang, S.K.5
Kim, K.Y.6
Rhee, S.D.7
Bae, M.A.8
Kim, K.R.9
Kim, S.G.10
Kim, S.Y.11
Sohn, S.K.12
Kang, N.S.13
Lee, J.O.14
Lee, D.H.15
Cheon, H.G.16
Kim, S.S.17
-
197
-
-
67649922154
-
Discovery of [beta]-homophenylalanine based pyrrolidin-2-ylm ethyl amides and sulfonamides as highly potent and selective inhibitors of dipeptidyl peptidase IV
-
Nordhoff, S.; Cerezo-Gálvez, S.; Deppe, H.; Hill, O.; López-Canet, M.; Rummey, C; Thiemann, M.; Matassa, V.G.; Edwards, PJ.; Feurer, A. Discovery of [beta]-homophenylalanine based pyrrolidin-2-ylm ethyl amides and sulfonamides as highly potent and selective inhibitors of dipeptidyl peptidase IV Bioorg. Med. Chem. Lett, 2009, 19 (15), 4201-4203.
-
(2009)
Bioorg. Med. Chem. Lett
, vol.19
, Issue.15
, pp. 4201-4203
-
-
Nordhoff, S.1
Cerezo-Gálvez, S.2
Deppe, H.3
Hill, O.4
López-Canet, M.5
Rummey, C.6
Thiemann, M.7
Matassa, V.G.8
Edwards, P.J.9
Feurer, A.10
-
198
-
-
79952364204
-
Discovery of potent dipeptidyl peptidase IV inhibitors derived from [beta]-aminoamides bearing substituted [1, 2, 3]-triazolopiperidines for the treatment of type 2 diabetes
-
Shan, Z.; Peng, M.; Fan, H.; Lu, Q.; Lu, P.; Zhao, C; Chen, Y Discovery of potent dipeptidyl peptidase IV inhibitors derived from [beta]-aminoamides bearing substituted [1, 2, 3]-triazolopiperidines for the treatment of type 2 diabetes. Bioorg. Med. Chem. Lett, 2011, 21 (6), 1731-1735.
-
(2011)
Bioorg. Med. Chem. Lett
, vol.21
, Issue.6
, pp. 1731-1735
-
-
Shan, Z.1
Peng, M.2
Fan, H.3
Lu, Q.4
Lu, P.5
Zhao, C.6
Chen, Y.7
-
199
-
-
41149089891
-
Fluoroolefins as amide bond mimics in dipeptidyl peptidase IV inhibitors
-
Edmondson, S.D.; Wei, L.; Xu, J.; Shang, J.; Xu, S.; Pang, J.; Chaudhary, A.; Dean, D.C.; He, H.; Leiting, B.; Lyons, K.A.; Patel, R.A.; Patel, S.B.; Scapin, G.; Wu, J.K.; Beconi, M.G.; Thornberry, N.A.; Weber, A.E. Fluoroolefins as amide bond mimics in dipeptidyl peptidase IV inhibitors. Bioorg. Med. Chem. Lett, 2008, 18 (7), 2409-2413.
-
(2008)
Bioorg. Med. Chem. Lett
, vol.18
, Issue.7
, pp. 2409-2413
-
-
Edmondson, S.D.1
Wei, L.2
Xu, J.3
Shang, J.4
Xu, S.5
Pang, J.6
Chaudhary, A.7
Dean, D.C.8
He, H.9
Leiting, B.10
Lyons, K.A.11
Patel, R.A.12
Patel, S.B.13
Scapin, G.14
Wu, J.K.15
Beconi, M.G.16
Thornberry, N.A.17
Weber, A.E.18
-
200
-
-
67650002790
-
Aminopiperidine-fused imidazoles as dipeptidyl peptidase-IV inhibitors
-
Edmondson, S.D.; Mastracchio, A.; Cox, J.M.; Eiermann, G.J.; He, H.; Lyons, K.A.; Patel, R.A.; Patel, S.B.; Petrov, A.; Scapin, G.; Wu, J.K.; Xu, S.; Zhu, B.; Thornberry, N.A.; Roy, R.S.; Weber, A.E. Aminopiperidine-fused imidazoles as dipeptidyl peptidase-IV inhibitors. Bioorg. Med. Chem. Lett, 2009, 19 (15), 4097-4101.
-
(2009)
Bioorg. Med. Chem. Lett
, vol.19
, Issue.15
, pp. 4097-4101
-
-
Edmondson, S.D.1
Mastracchio, A.2
Cox, J.M.3
Eiermann, G.J.4
He, H.5
Lyons, K.A.6
Patel, R.A.7
Patel, S.B.8
Petrov, A.9
Scapin, G.10
Wu, J.K.11
Xu, S.12
Zhu, B.13
Thornberry, N.A.14
Roy, R.S.15
Weber, A.E.16
-
201
-
-
78650744466
-
Design and synthesis of 3-pyridylacetamide derivatives as dipeptidyl peptidase IV (DPP-4) inhibitors targeting a bidentate interaction with Arg125
-
Miyamoto, Y; Banno, Y; Yamashita, T.; Fujimoto, T.; Oi, S.; Moritoh, Y; Asakawa, T.; Kataoka, O.; Takeuchi, K.; Suzuki, N; Ikedo, K.; Kosaka, T.; Tsubotani, S.; Tani, A.; Funami, M.; Amano, M.; Yamamoto, Y; Aertgeerts, K.; Yano, J.; Maezaki, H. Design and synthesis of 3-pyridylacetamide derivatives as dipeptidyl peptidase IV (DPP-4) inhibitors targeting a bidentate interaction with Arg125. Bioorg. Med. Chem., 2011, 19 (1), 172-185.
-
(2011)
Bioorg. Med. Chem.
, vol.19
, Issue.1
, pp. 172-185
-
-
Miyamoto, Y.1
Banno, Y.2
Yamashita, T.3
Fujimoto, T.4
Oi, S.5
Moritoh, Y.6
Asakawa, T.7
Kataoka, O.8
Takeuchi, K.9
Suzuki, N.10
Ikedo, K.11
Kosaka, T.12
Tsubotani, S.13
Tani, A.14
Funami, M.15
Amano, M.16
Yamamoto, Y.17
Aertgeerts, K.18
Yano, J.19
Maezaki, H.20
more..
-
202
-
-
0014014125
-
Sorbitol pathway: Presence in nerve and cord with substrate accumulation in diabetes
-
Gabbay, K.H.; Merola, L.O.; Field, R.A. Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes. Science, 1966, 151 (3707), 209-210.
-
(1966)
Science
, vol.151
, Issue.3707
, pp. 209-210
-
-
Gabbay, K.H.1
Merola, L.O.2
Field, R.A.3
-
203
-
-
78649860273
-
Long-term complications of diabetes mellitus
-
Nathan, DM. Long-term complications of diabetes mellitus. N. Engl. J. Med., 1988, 318 (20), 1315-1321.
-
(1988)
N. Engl. J. Med.
, vol.318
, Issue.20
, pp. 1315-1321
-
-
Nathan, D.M.1
-
204
-
-
0000841548
-
Formation of polyols by the lens of the lens of the rat with sugar cataract
-
van Heyningen, R. Formation of polyols by the lens of the lens of the rat with sugar cataract. Nature (Lond.), 1959, 184 (S4), 194-195.
-
(1959)
Nature (Lond.)
, vol.184
, Issue.S4
, pp. 194-195
-
-
Van Heyningen, R.1
-
205
-
-
0031752685
-
Global Burden of Diabetes, 1995-2025. Prevalence, Numeric Estimates, and Projections
-
King, H.; Aubert, R.E.; Herman, W.H. Global Burden of Diabetes, 1995-2025. Prevalence, Numeric Estimates, and Projections. Diabetes Care., 1998, 21 (9), 1414-1431.
-
(1998)
Diabetes Care.
, vol.21
, Issue.9
, pp. 1414-1431
-
-
King, H.1
Aubert, R.E.2
Herman, W.H.3
-
206
-
-
0027730267
-
Lessons Learned from Use of Cyclosporine for Insulin-Dependent Diabetes Mellitus
-
Mahon, J.L.; Dupre, J.; Stiller, C.R. Lessons Learned from Use of Cyclosporine for Insulin-Dependent Diabetes Mellitus. Ann. N.Y. Acad. Sci., 1993, 696 (1), 351-363.
-
(1993)
Ann. N.Y. Acad. Sci.
, vol.696
, Issue.1
, pp. 351-363
-
-
Mahon, J.L.1
Dupre, J.2
Stiller, C.R.3
-
207
-
-
0035856980
-
Biochemistry and Molecular Cell Biology of Diabetic Complications
-
Brownlee, M. Biochemistry and Molecular Cell Biology of Diabetic Complications. Nature, 2001, 414 (6865), 813-820.
-
(2001)
Nature
, vol.414
, Issue.6865
, pp. 813-820
-
-
Brownlee, M.1
-
208
-
-
20444380690
-
Cellular Mechanisms and Treatment of Diabetes Vascular Complications Converge on Reactive Oxygen Species
-
Whiteside, C.I. Cellular Mechanisms and Treatment of Diabetes Vascular Complications Converge on Reactive Oxygen Species. Curr. Hypertens. Rep., 2005, 7 (2), 148-154.
-
(2005)
Curr. Hypertens. Rep.
, vol.7
, Issue.2
, pp. 148-154
-
-
Whiteside, C.I.1
-
209
-
-
0027934146
-
Aldose Reductase Inhibitors and Their Potential for the Treatment of Diabetic Complications
-
Tomlinson, D.R.; Stevens, E.J.; Diemel, L.T. Aldose Reductase Inhibitors and Their Potential for the Treatment of Diabetic Complications. Trends Pharmacol. Sci., 1994, 15 (8), 293-297.
-
(1994)
Trends Pharmacol. Sci.
, vol.15
, Issue.8
, pp. 293-297
-
-
Tomlinson, D.R.1
Stevens, E.J.2
Diemel, L.T.3
-
210
-
-
0023899991
-
The Role of Aldose Reductase in the Development of Diabetic Complications
-
Kador, P.F. The Role of Aldose Reductase in the Development of Diabetic Complications. Med. Res. Rev., 1988, 8 (3), 325-352.
-
(1988)
Med. Res. Rev.
, vol.8
, Issue.3
, pp. 325-352
-
-
Kador, P.F.1
-
211
-
-
0023913225
-
The involvement of aldose reductase in diabetic complications
-
Kinoshita, J.H.; Nishimura, C. The involvement of aldose reductase in diabetic complications. Diabetes Metab. Rev., 1988, 4 (4), 323-337.
-
(1988)
Diabetes Metab. Rev.
, vol.4
, Issue.4
, pp. 323-337
-
-
Kinoshita, J.H.1
Nishimura, C.2
-
212
-
-
0021828899
-
Aldose reductase inhibitors: A potential new class of agents for the pharmacological control of certain diabetic complications
-
Kador, P.F.; Kinoshita, J.H.; Sharpless, N.E. Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications. J. Med. Chem., 1985, 28 (7), 841-849.
-
(1985)
J. Med. Chem.
, vol.28
, Issue.7
, pp. 841-849
-
-
Kador, P.F.1
Kinoshita, J.H.2
Sharpless, N.E.3
-
213
-
-
65649103414
-
Aldose reductase enzyme and its implication tomajor health problems of the 21st century
-
Alexiou, P.; Pegklidou, K.; Chatzopoulou, M.; Nicolaou, I.; Demopoulos, V.J. Aldose reductase enzyme and its implication tomajor health problems of the 21st century. Curr. Med. Chem., 2009, 16 (6), 734-752.
-
(2009)
Curr. Med. Chem.
, vol.16
, Issue.6
, pp. 734-752
-
-
Alexiou, P.1
Pegklidou, K.2
Chatzopoulou, M.3
Nicolaou, I.4
Demopoulos, V.J.5
-
214
-
-
0000930578
-
Isolation and properties of lens aldose reductase
-
Hayman, S.; Kinoshita, J.H. Isolation and properties of lens aldose reductase. J. Biol. Chem., 1965, 240 (2), 877-882.
-
(1965)
J. Biol. Chem.
, vol.240
, Issue.2
, pp. 877-882
-
-
Hayman, S.1
Kinoshita, J.H.2
-
215
-
-
0015887637
-
Polyol accumulation in galactosemic and diabetic rats: Control by an aldose reductase inhaibitor
-
Dvornik, D.; Simard-Duquesne, N.; Keami, M.; Sestanj, K. Polyol accumulation in galactosemic and diabetic rats: control by an aldose reductase inhaibitor. Science, 1973, 182 (4117), 1146-1148.
-
(1973)
Science
, vol.182
, Issue.4117
, pp. 1146-1148
-
-
Dvornik, D.1
Simard-Duquesne, N.2
Keami, M.3
Sestanj, K.4
-
216
-
-
0021323690
-
N-[5-(Trifluoromethyl)-6-methoxy-1-naphthalenyl]thioxomethyl] -N-methylglycine (Tolrestat), a potent, orally active aldose reductase inhibitor
-
Sestanj, K.; Bellini, F.; Fung, S.; Abraham, N.; Treasurywala, A.; Humber, L.; Simard-Duquesne, N.; Dvornik, D. N-[5-(Trifluoromethyl)-6-methoxy-1- naphthalenyl]thioxomethyl]-N-methylglycine (Tolrestat), a potent, orally active aldose reductase inhibitor. J. Med. Chem., 1984, 27 (3), 255-256.
-
(1984)
J. Med. Chem.
, vol.27
, Issue.3
, pp. 255-256
-
-
Sestanj, K.1
Bellini, F.2
Fung, S.3
Abraham, N.4
Treasurywala, A.5
Humber, L.6
Simard-Duquesne, N.7
Dvornik, D.8
-
217
-
-
0020526445
-
Effect of a new aldose reductase inhibitor (E)-3-carboxymethyl-5-[(2E)- methyl-3-phenylpropenyl-idene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats
-
Kikkawa, R.; Hatanaka, I.; Yasuda, H.; Kobayashi, N.; Shigeta, Y.; Terashima, H.; Morimura, T.; Tsuboshima, M. Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenyl-idene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats. Diabetologia, 1983, 24 (4), 290-292.
-
(1983)
Diabetologia
, vol.24
, Issue.4
, pp. 290-292
-
-
Kikkawa, R.1
Hatanaka, I.2
Yasuda, H.3
Kobayashi, N.4
Shigeta, Y.5
Terashima, H.6
Morimura, T.7
Tsuboshima, M.8
-
218
-
-
0025967888
-
Novel, potent aldose reductase inhibitors: 3, 4-dihydro-4-oxo-3-[[5- (trifluoromethyl)-2-benzothiazolyl] methyl]-1-phthalazineacetic acid (zopolrestat) and congeners
-
Mylari, B.L.; Larson, E.R.; Beyer, T.A.; Zembrowski, W.J.; Aldinger, C.E.; Dee, M.F.; Siegel, T.W.; Singleton, D.H. Novel, potent aldose reductase inhibitors: 3, 4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl] methyl]-1-phthalazineacetic acid (zopolrestat) and congeners. J. Med. Chem., 1991, 34 (1), 108-122.
-
(1991)
J. Med. Chem.
, vol.34
, Issue.1
, pp. 108-122
-
-
Mylari, B.L.1
Larson, E.R.2
Beyer, T.A.3
Zembrowski, W.J.4
Aldinger, C.E.5
Dee, M.F.6
Siegel, T.W.7
Singleton, D.H.8
-
219
-
-
0025956755
-
Characterization of a novel aldose reductase inhibitor FR74366 and its effects on diabetic cataract and neuropathy in the rat
-
Ao, S.; Shingu, Y.; Kikuchi, C.; Takano, Y.; Nomura, K.; Fujiwara, T.; Ohkubo, Y.; Notsu, Y.; Yamaguchi, I. Characterization of a novel aldose reductase inhibitor, FR74366, and its effects on diabetic cataract and neuropathy in the rat. Metabolism., 1991, 40 (1), 77-87.
-
(1991)
Metabolism.
, vol.40
, Issue.1
, pp. 77-87
-
-
Ao, S.1
Shingu, Y.2
Kikuchi, C.3
Takano, Y.4
Nomura, K.5
Fujiwara, T.6
Ohkubo, Y.7
Notsu, Y.8
Yamaguchi, I.9
-
220
-
-
0021814782
-
Properties of ICI 128, 436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat
-
Stribling, D.; Mirrlees, D.J.; Harrison, H.E.; Earl, D.C. Properties of ICI 128, 436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat. Metabolism., 1985, 34 (4), 336-344.
-
(1985)
Metabolism.
, vol.34
, Issue.4
, pp. 336-344
-
-
Stribling, D.1
Mirrlees, D.J.2
Harrison, H.E.3
Earl, D.C.4
-
221
-
-
20944432343
-
Discovery of 3-[(4, 5, 7-trifluorobenzothiazol-2-yl)methyl]indole-N- acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications
-
Van Zandt, M.C.; Jones, M.L.; Gunn, D.E.; Geraci, L.S.; Jones, J.H.; Sawicki, D.R.; Sredy, J.; Jacot, J.L.; DiCioccio, A.T.; Petrova, T.; Mitschler, A.; Podjarny, A.D. Discovery of 3-[(4, 5, 7-trifluorobenzothiazol-2-yl)methyl] indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications. J. Med. Chem., 2005, 48 (9), 3141-3152.
-
(2005)
J. Med. Chem.
, vol.48
, Issue.9
, pp. 3141-3152
-
-
Van Zandt, M.C.1
Jones, M.L.2
Gunn, D.E.3
Geraci, L.S.4
Jones, J.H.5
Sawicki, D.R.6
Sredy, J.7
Jacot, J.L.8
Dicioccio, A.T.9
Petrova, T.10
Mitschler, A.11
Podjarny, A.D.12
-
222
-
-
27444440949
-
Naphtho[1, 2-d]isothiazole acetic acid derivatives as a novel class of selective aldose reductase inhibitors
-
Da Settimo, F.; Primofiore, G.; La Motta, C.; Sartini, S.; Taliani, S.; Simorini, F.; Marini, A.M.; Lavecchia, A.; Novellino, E.; Boldrini, E. Naphtho[1, 2-d]isothiazole acetic acid derivatives as a novel class of selective aldose reductase inhibitors. J. Med. Chem., 2005, 48 (22), 6897-6907.
-
(2005)
J. Med. Chem.
, vol.48
, Issue.22
, pp. 6897-6907
-
-
Da Settimo, F.1
Primofiore, G.2
La Motta, C.3
Sartini, S.4
Taliani, S.5
Simorini, F.6
Marini, A.M.7
Lavecchia, A.8
Novellino, E.9
Boldrini, E.10
-
223
-
-
0019287523
-
Synthesis and Aldose Reductase Inhibitory Activity of 7-Sulfamoylxanthone-2-carboxylic Acids
-
Pfister, J.R.; Wymann, W.E.; Mahoney, J.M.; Waterbury, L.D. Synthesis and Aldose Reductase Inhibitory Activity of 7-Sulfamoylxanthone-2-carboxylic Acids. J. Med. Chem., 1980, 23 (11), 1264-1267.
-
(1980)
J. Med. Chem.
, vol.23
, Issue.11
, pp. 1264-1267
-
-
Pfister, J.R.1
Wymann, W.E.2
Mahoney, J.M.3
Waterbury, L.D.4
-
224
-
-
0023267954
-
Novel Inhibitors of Rat Lens Aldose Reductase: N-[[(Substituted amino) phenyl]sulfonyl]glycines
-
Mayfield, CA.; DeRuiter, J. Novel Inhibitors of Rat Lens Aldose Reductase: N-[[(Substituted amino) phenyl]sulfonyl]glycines. J. Med. Chem., 1987, 30 (9), 1595-1598.
-
(1987)
J. Med. Chem.
, vol.30
, Issue.9
, pp. 1595-1598
-
-
Mayfield, C.A.1
Deruiter, J.2
-
225
-
-
78649855244
-
Acetic Acid Derivatives of 3, 4-Dihydro-2H-1 2, 4-benzothiadiazine 1, 1-Dioxide as a Novel Class of Potent Aldose Reductase Inhibitors
-
Chen, X.; Zhu, C; Guo, F.; Qiu, X.; Yang, Y.; Zhang, S.; He, M.; Parveen, S.; Jing, C; Li, Y; Ma, B. Acetic Acid Derivatives of 3, 4-Dihydro-2H-1, 2, 4-benzothiadiazine 1, 1-Dioxide as a Novel Class of Potent Aldose Reductase Inhibitors. J. Med. Chem., 2010, 53 (23), 8330-8344.
-
(2010)
J. Med. Chem.
, vol.53
, Issue.23
, pp. 8330-8344
-
-
Chen, X.1
Zhu, C.2
Guo, F.3
Qiu, X.4
Yang, Y.5
Zhang, S.6
He, M.7
Parveen, S.8
Jing, C.9
Li, Y.10
Ma, B.11
-
226
-
-
79953226757
-
Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold
-
Chen, X.; Yang, Y; Ma, B.; Zhang, S.; He, M.; Gui, D.; Hussain, S.; Jing, C; Zhu, C; Yu, Q.; Liu, Y Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold. Eur. J. Med. Chem., 2011, 46 (5), 1536-1544.
-
(2011)
Eur. J. Med. Chem.
, vol.46
, Issue.5
, pp. 1536-1544
-
-
Chen, X.1
Yang, Y.2
Ma, B.3
Zhang, S.4
He, M.5
Gui, D.6
Hussain, S.7
Jing, C.8
Zhu, C.9
Yu, Q.10
Liu, Y.11
-
227
-
-
80655136956
-
1, 2-Benzothiazine 1, 1-dioxide carboxylate derivatives as novel potent inhibitors of aldose reductase
-
Chen, X.; Zhang, S.; Yang, Y; Hussain, S.; He, M.; Gui, D.; Ma, B.; Jing, C; Qiao, Z.; Zhu, C; Yu, Q. 1, 2-Benzothiazine 1, 1-dioxide carboxylate derivatives as novel potent inhibitors of aldose reductase. Bioorg. Med. Chem., 2011, 19 (23), 7262-7269.
-
(2011)
Bioorg. Med. Chem.
, vol.19
, Issue.23
, pp. 7262-7269
-
-
Chen, X.1
Zhang, S.2
Yang, Y.3
Hussain, S.4
He, M.5
Gui, D.6
Ma, B.7
Jing, C.8
Qiao, Z.9
Zhu, C.10
Yu, Q.11
-
228
-
-
0023189440
-
Development of potent aldose reductase Inhibitors having a hydantoin structure
-
Miwa, I; Hirano, M.; Inagaki, K.; Belbeoch, C; Okuda, A.J. Development of potent aldose reductase Inhibitors having a hydantoin structure. Biochem. Pharmacol, 1987, 36 (17), 2789-2794.
-
(1987)
Biochem. Pharmacol
, vol.36
, Issue.17
, pp. 2789-2794
-
-
Miwa, I.1
Hirano, M.2
Inagaki, K.3
Belbeoch, C.4
Okuda, A.J.5
-
229
-
-
0025362393
-
Vivo activities of aldose reductase inhibitors having a 1-(arylsulfonyl)hydantoin structure
-
Miwa, I; Hirano, M.; Kanbara, M.; Okuda, J. In vivo activities of aldose reductase inhibitors having a 1-(arylsulfonyl)hydantoin structure. Biochem. Pharmacol, 1990, 40 (2), 303-307.
-
(1990)
Biochem. Pharmacol
, vol.40
, Issue.2
, pp. 303-307
-
-
Miwa, I.1
Hirano, M.2
Kanbara, M.3
Okuda, J.4
-
230
-
-
0025737815
-
Properties of novel aldose reductase inhibitors, M16209 and M16287, in comparison with known inhibitors, ONO-2235 and sorbinil
-
Kato, K.; Nakayama, K.; Mizota, M.; Miwa, I; Okuda, J. Properties of novel aldose reductase inhibitors, M16209 and M16287, in comparison with known inhibitors, ONO-2235 and sorbinil. Chem. Pharm. Bull, 1991, 39 (6), 1540-1545.
-
(1991)
Chem. Pharm. Bull
, vol.39
, Issue.6
, pp. 1540-1545
-
-
Kato, K.1
Nakayama, K.2
Mizota, M.3
Miwa, I.4
Okuda, J.5
-
231
-
-
0026026047
-
Effects of novel aldose reductase inhibitors, M16209 and M16287, on streptozotocin-induced diabetic neuropathy in rats
-
Kato, K.; Nakayama, K.; Ohta, M.; Murakami, N; Murakami, K.; Mizota, M.; Miwa, I; Okuda, J. Effects of novel aldose reductase inhibitors, M16209 and M16287, on streptozotocin-induced diabetic neuropathy in rats. Eur. J. Pharmacol, 1991, 193 (2), 185-191.
-
(1991)
Eur. J. Pharmacol
, vol.193
, Issue.2
, pp. 185-191
-
-
Kato, K.1
Nakayama, K.2
Ohta, M.3
Murakami, N.4
Murakami, K.5
Mizota, M.6
Miwa, I.7
Okuda, J.8
-
232
-
-
84863762042
-
-
WO 9008761 (A1)
-
Brittain, D.R.; Brown, S.P; Cooper, A.L.; Longridge, J.L.; Morris, J.J.; Preston, J.; Slater, L. Phenylsulphone Derivatives. WO 9008761 (A1), 1991.
-
(1991)
Phenylsulphone Derivatives
-
-
Brittain, D.R.1
Brown, S.P.2
Cooper, A.L.3
Longridge, J.L.4
Morris, J.J.5
Preston, J.6
Slater, L.7
-
233
-
-
0028937645
-
Kinetic characteristics of zeneca zd5522, a potent inhibitor of human and bovine lens aldose reductase
-
Cook, P.N.; Ward, W.H.J.; Petrash, J.M.; Mirrlees, D.J.; Sennitt, CM.; Carey, F.; Preston, J.; Brxttain, D.R.; Tuffin, D. P.; Howe, R. Kinetic characteristics of zeneca zd5522, a potent inhibitor of human and bovine lens aldose reductase. Biochem. Pharmacol, 1995, 49 (8), 1043-1049.
-
(1995)
Biochem. Pharmacol
, vol.49
, Issue.8
, pp. 1043-1049
-
-
Cook, P.N.1
Ward, W.H.J.2
Petrash, J.M.3
Mirrlees, D.J.4
Sennitt, C.M.5
Carey, F.6
Preston, J.7
Brxttain, D.R.8
Tuffin, D.P.9
Howe, R.10
-
234
-
-
0033867728
-
Synthesis and aldose reductase inhibitory activities of novel Nnitromethylsulfonanilide derivatives
-
Inoue, J.; Cui, Y; Sakai, O.; Nakamura, Y; Kogiso, H.; Kador, P. Synthesis and aldose reductase inhibitory activities of novel Nnitromethylsulfonanilide derivatives. Bioorg. Med. Chem., 2000, 8 (8), 2167-2173.
-
(2000)
Bioorg. Med. Chem.
, vol.8
, Issue.8
, pp. 2167-2173
-
-
Inoue, J.1
Cui, Y.2
Sakai, O.3
Nakamura, Y.4
Kogiso, H.5
Kador, P.6
-
235
-
-
12444318652
-
A Highly Selective, Non-Hydantoin, Non-Carboxylic Acid Inhibitor of Aldose Reductase with Potent Oral Activity in Diabetic Rat Models: 6-(5-Chloro-3-methylbenzofuran-2-sulfonyl)-2-H-pyridazin-3-one
-
Mylari, B.L.; Armento, S.J.; Beebe, D.A.; Conn, E.L.; Coutcher, J.B.; Dina, M.S.; O'Gorman, M.T.; Linhares, M.C.; Martin, W.H.; Oates, P.J.; Tess, D.A.; Withbroe, G.J.; Zembrowski, W.J. A Highly Selective, Non-Hydantoin, Non-Carboxylic Acid Inhibitor of Aldose Reductase with Potent Oral Activity in Diabetic Rat Models: 6-(5-Chloro-3-methylbenzofuran-2-sulfonyl)-2-H-pyridazin-3- one. J. Med. Chem., 2003, 46 (12), 2283-2286.
-
(2003)
J. Med. Chem.
, vol.46
, Issue.12
, pp. 2283-2286
-
-
Mylari, B.L.1
Armento, S.J.2
Beebe, D.A.3
Conn, E.L.4
Coutcher, J.B.5
Dina, M.S.6
O'Gorman, M.T.7
Linhares, M.C.8
Martin, W.H.9
Oates, P.J.10
Tess, D.A.11
Withbroe, G.J.12
Zembrowski, W.J.13
-
236
-
-
26444477394
-
A Novel Series of Non-Carboxylic Acid, Non-Hydantoin Inhibitors of Aldose Reductase with Potent Oral Activity in Diabetic Rat Models: 6-(5-Chloro-3-methylbenzofuran-2-sulfonyl)-2H-pyridazin-3-one and Congeners
-
Mylari, B.L.; Armento, S.J.; Beebe, D.A.; Conn, E.L.; Coutcher, J.B.; Dina, M.S.; O'Gorman, M.T.; Linhares, M.C.; Martin, W.H.; Oates, P.J.; Tess, D.A.; Withbroe, G.J.; Zembrowski, W.J. A Novel Series of Non-Carboxylic Acid, Non-Hydantoin Inhibitors of Aldose Reductase with Potent Oral Activity in Diabetic Rat Models: 6-(5-Chloro-3-methylbenzofuran-2-sulfonyl)-2H-pyridazin-3- one and Congeners. J. Med. Chem., 2005, 48 (20), 6326-6339.
-
(2005)
J. Med. Chem.
, vol.48
, Issue.20
, pp. 6326-6339
-
-
Mylari, B.L.1
Armento, S.J.2
Beebe, D.A.3
Conn, E.L.4
Coutcher, J.B.5
Dina, M.S.6
O'Gorman, M.T.7
Linhares, M.C.8
Martin, W.H.9
Oates, P.J.10
Tess, D.A.11
Withbroe, G.J.12
Zembrowski, W.J.13
-
237
-
-
41649105654
-
Design and synthesis of N-3, 5-difluoro-4-hydroxyphenyl) benzenesulfonamides as aldose reductase inhibitors
-
Alexiou, P.; Nicolaou, I; Stefek, M.; Kristl, A.; Demopoulos, V.J. Design and synthesis of N-(3, 5-difluoro-4-hydroxyphenyl)benzenesulfonamides as aldose reductase inhibitors. Bioorg. Med. Chem., 2008, 16 (7), 3926-3932.
-
(2008)
Bioorg. Med. Chem.
, vol.16
, Issue.7
, pp. 3926-3932
-
-
Alexiou, P.1
Nicolaou, I.2
Stefek, M.3
Kristl, A.4
Demopoulos, V.J.5
-
238
-
-
42749087181
-
Binding mode analyses and pharmacophore model development for sulfonamide chalcone derivatives, a new class of a-glucosidase inhibitors
-
Bharatham, K.; Bharatham, N; Park, K.H.; Lee, K.W. Binding mode analyses and pharmacophore model development for sulfonamide chalcone derivatives, a new class of a-glucosidase inhibitors. J. Mol Graph. Model, 2008, 26 (8), 1202-1212.
-
(2008)
J. Mol Graph. Model
, vol.26
, Issue.8
, pp. 1202-1212
-
-
Bharatham, K.1
Bharatham, N.2
Park, K.H.3
Lee, K.W.4
|